Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for PATZ1_KLF4
Z-value: 1.92
Motif logo
Transcription factors associated with PATZ1_KLF4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
|
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| KLF4 | hg19_v2_chr9_-_110251836_110251927 | 0.54 | 5.2e-18 | Click! |
| PATZ1 | hg19_v2_chr22_-_31741757_31741770 | 0.19 | 4.3e-03 | Click! |
Activity profile of PATZ1_KLF4 motif
Sorted Z-values of PATZ1_KLF4 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr18_+_11981427 | 44.41 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr2_+_10183651 | 33.76 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
| chr22_-_50746027 | 33.67 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
| chr17_-_42276574 | 30.46 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr9_-_110251836 | 30.22 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
| chr17_-_42277203 | 29.38 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr19_+_16435625 | 29.27 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr18_+_11981547 | 28.48 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr18_+_11981014 | 28.00 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr22_-_50746001 | 27.53 |
ENST00000359337.4
|
PLXNB2
|
plexin B2 |
| chr19_+_1071203 | 26.14 |
ENST00000543365.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr20_-_62711259 | 26.05 |
ENST00000332298.5
|
RGS19
|
regulator of G-protein signaling 19 |
| chr11_-_64512273 | 26.00 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr8_+_1711918 | 25.97 |
ENST00000331222.4
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
| chr6_+_37137939 | 24.96 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr11_-_407103 | 24.95 |
ENST00000526395.1
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
| chr19_-_2051223 | 24.81 |
ENST00000309340.7
ENST00000589534.1 ENST00000250896.3 ENST00000589509.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr11_-_73693875 | 24.32 |
ENST00000536983.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
| chr17_-_76124711 | 23.86 |
ENST00000306591.7
ENST00000590602.1 |
TMC6
|
transmembrane channel-like 6 |
| chr14_+_105953204 | 23.63 |
ENST00000409393.2
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr20_-_62710832 | 23.52 |
ENST00000395042.1
|
RGS19
|
regulator of G-protein signaling 19 |
| chr1_+_226250379 | 23.07 |
ENST00000366815.3
ENST00000366814.3 |
H3F3A
|
H3 histone, family 3A |
| chr11_-_64512469 | 23.05 |
ENST00000377485.1
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr4_+_154387480 | 22.92 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
| chr2_+_238600788 | 22.91 |
ENST00000289175.6
ENST00000244815.5 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr19_-_2050852 | 22.85 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr7_+_98972298 | 22.52 |
ENST00000252725.5
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
| chr1_+_43148625 | 22.47 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
| chr22_+_23237555 | 22.47 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
| chr1_+_28199047 | 21.63 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
| chr15_+_63569785 | 21.55 |
ENST00000380343.4
ENST00000560353.1 |
APH1B
|
APH1B gamma secretase subunit |
| chr19_+_1065922 | 21.48 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr11_+_117049445 | 21.39 |
ENST00000324225.4
ENST00000532960.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
| chr11_-_64512803 | 21.04 |
ENST00000377489.1
ENST00000354024.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr14_-_106092403 | 20.98 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
| chr10_+_135192695 | 20.88 |
ENST00000368539.4
ENST00000278060.5 ENST00000357296.3 |
PAOX
|
polyamine oxidase (exo-N4-amino) |
| chr14_+_105953246 | 20.81 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr19_+_39897453 | 20.80 |
ENST00000597629.1
ENST00000248673.3 ENST00000594045.1 ENST00000594442.1 |
ZFP36
|
ZFP36 ring finger protein |
| chr14_-_106174960 | 20.56 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
| chr19_+_35645817 | 20.41 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr6_-_159065741 | 20.34 |
ENST00000367085.3
ENST00000367089.3 |
DYNLT1
|
dynein, light chain, Tctex-type 1 |
| chr2_+_238600933 | 20.29 |
ENST00000420665.1
ENST00000392000.4 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr22_-_43583079 | 20.27 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
| chr12_+_111843749 | 20.17 |
ENST00000341259.2
|
SH2B3
|
SH2B adaptor protein 3 |
| chr19_+_7701985 | 20.02 |
ENST00000595950.1
ENST00000441779.2 ENST00000221283.5 ENST00000414284.2 |
STXBP2
|
syntaxin binding protein 2 |
| chr7_-_102252038 | 20.02 |
ENST00000461209.1
|
RASA4
|
RAS p21 protein activator 4 |
| chr19_+_35645618 | 19.96 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr16_-_431936 | 19.92 |
ENST00000250930.3
ENST00000431232.2 |
TMEM8A
|
transmembrane protein 8A |
| chr5_-_180237445 | 19.87 |
ENST00000393340.3
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr11_-_73694346 | 19.86 |
ENST00000310473.3
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
| chr15_+_65134088 | 19.75 |
ENST00000323544.4
ENST00000437723.1 |
PLEKHO2
AC069368.3
|
pleckstrin homology domain containing, family O member 2 Uncharacterized protein |
| chr19_+_18284477 | 19.67 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
| chr19_-_14629224 | 19.58 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
| chr3_+_52444651 | 19.51 |
ENST00000327906.3
|
PHF7
|
PHD finger protein 7 |
| chr20_-_39317868 | 19.44 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
| chr16_-_1993260 | 19.34 |
ENST00000361871.3
|
MSRB1
|
methionine sulfoxide reductase B1 |
| chr11_+_67806467 | 19.14 |
ENST00000265686.3
ENST00000524598.1 ENST00000529657.1 |
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
| chr19_+_1067144 | 19.07 |
ENST00000313093.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr3_-_126194707 | 18.93 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
| chr11_-_46142948 | 18.93 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
| chr21_-_46330545 | 18.92 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr22_+_43547937 | 18.79 |
ENST00000329563.4
|
TSPO
|
translocator protein (18kDa) |
| chr8_-_37756972 | 18.72 |
ENST00000330843.4
ENST00000522727.1 ENST00000287263.4 |
RAB11FIP1
|
RAB11 family interacting protein 1 (class I) |
| chr19_+_1067492 | 18.70 |
ENST00000586866.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr6_+_292459 | 18.68 |
ENST00000419235.2
ENST00000605035.1 ENST00000605863.1 |
DUSP22
|
dual specificity phosphatase 22 |
| chr3_+_50649302 | 18.64 |
ENST00000446044.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
| chr16_-_88717482 | 18.63 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
| chr9_-_139891165 | 18.62 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
| chr11_+_2466218 | 18.42 |
ENST00000155840.5
|
KCNQ1
|
potassium voltage-gated channel, KQT-like subfamily, member 1 |
| chr21_-_10990888 | 18.37 |
ENST00000298232.7
|
TPTE
|
transmembrane phosphatase with tensin homology |
| chr15_+_63569731 | 18.32 |
ENST00000261879.5
|
APH1B
|
APH1B gamma secretase subunit |
| chr2_+_10184302 | 18.20 |
ENST00000440320.1
ENST00000535335.1 |
KLF11
|
Kruppel-like factor 11 |
| chr1_-_19811962 | 18.15 |
ENST00000375142.1
ENST00000264202.6 |
CAPZB
|
capping protein (actin filament) muscle Z-line, beta |
| chr17_+_78075361 | 18.07 |
ENST00000577106.1
ENST00000390015.3 |
GAA
|
glucosidase, alpha; acid |
| chr10_+_82214052 | 17.85 |
ENST00000372157.2
ENST00000372164.3 ENST00000372158.1 ENST00000341863.6 |
TSPAN14
|
tetraspanin 14 |
| chr14_-_106054659 | 17.83 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
| chr7_-_149470540 | 17.82 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
| chr1_-_111746966 | 17.80 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
| chr5_-_180229833 | 17.80 |
ENST00000307826.4
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
| chr22_-_26986045 | 17.80 |
ENST00000442495.1
ENST00000440953.1 ENST00000450022.1 ENST00000338754.4 |
TPST2
|
tyrosylprotein sulfotransferase 2 |
| chr14_-_106111127 | 17.75 |
ENST00000390545.2
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
| chr17_-_80231300 | 17.63 |
ENST00000398519.5
ENST00000580446.1 |
CSNK1D
|
casein kinase 1, delta |
| chr2_-_37899323 | 17.47 |
ENST00000295324.3
ENST00000457889.1 |
CDC42EP3
|
CDC42 effector protein (Rho GTPase binding) 3 |
| chr16_-_31214051 | 17.45 |
ENST00000350605.4
|
PYCARD
|
PYD and CARD domain containing |
| chr1_-_153517473 | 17.41 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
| chr19_-_55658650 | 17.38 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr6_+_138188551 | 17.34 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
| chr19_+_797392 | 17.33 |
ENST00000350092.4
ENST00000349038.4 ENST00000586481.1 ENST00000585535.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
| chrX_-_153599578 | 17.18 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
| chr19_-_10464570 | 17.13 |
ENST00000529739.1
|
TYK2
|
tyrosine kinase 2 |
| chr5_-_1112141 | 17.07 |
ENST00000264930.5
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7 |
| chr19_-_663277 | 17.06 |
ENST00000292363.5
|
RNF126
|
ring finger protein 126 |
| chr7_+_98972345 | 17.02 |
ENST00000418347.2
ENST00000429246.1 ENST00000417330.1 ENST00000431816.1 ENST00000427217.1 ENST00000458033.1 ENST00000451682.1 |
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
| chr18_+_77155942 | 16.93 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
| chr19_+_1941117 | 16.79 |
ENST00000255641.8
|
CSNK1G2
|
casein kinase 1, gamma 2 |
| chr17_-_76124812 | 16.58 |
ENST00000592063.1
ENST00000589271.1 ENST00000322933.4 ENST00000589553.1 |
TMC6
|
transmembrane channel-like 6 |
| chr1_+_2487800 | 16.25 |
ENST00000355716.4
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14 |
| chr14_-_74960030 | 16.24 |
ENST00000553490.1
ENST00000557510.1 |
NPC2
|
Niemann-Pick disease, type C2 |
| chr21_-_44846999 | 16.21 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr19_+_1067271 | 16.19 |
ENST00000536472.1
ENST00000590214.1 |
HMHA1
|
histocompatibility (minor) HA-1 |
| chr1_-_19811996 | 16.14 |
ENST00000264203.3
ENST00000401084.2 |
CAPZB
|
capping protein (actin filament) muscle Z-line, beta |
| chr22_+_43547520 | 16.06 |
ENST00000337554.3
ENST00000396265.3 ENST00000583777.1 |
TSPO
|
translocator protein (18kDa) |
| chr22_-_50946113 | 16.04 |
ENST00000216080.5
ENST00000474879.2 ENST00000380796.3 |
LMF2
|
lipase maturation factor 2 |
| chr22_+_38005033 | 16.04 |
ENST00000447515.1
ENST00000406772.1 ENST00000431745.1 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
| chr17_+_73521763 | 16.03 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
| chrX_-_153191708 | 15.97 |
ENST00000393721.1
ENST00000370028.3 |
ARHGAP4
|
Rho GTPase activating protein 4 |
| chr22_-_17680472 | 15.91 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
| chr2_-_197036289 | 15.89 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
| chr17_-_80606304 | 15.76 |
ENST00000392325.4
|
WDR45B
|
WD repeat domain 45B |
| chr3_+_53195136 | 15.66 |
ENST00000394729.2
ENST00000330452.3 |
PRKCD
|
protein kinase C, delta |
| chr20_+_55966444 | 15.63 |
ENST00000356208.5
ENST00000440234.2 |
RBM38
|
RNA binding motif protein 38 |
| chr5_-_131826457 | 15.59 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
| chr19_+_50016411 | 15.57 |
ENST00000426395.3
ENST00000600273.1 ENST00000599988.1 |
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
| chr17_+_76164639 | 15.54 |
ENST00000225777.3
ENST00000585591.1 ENST00000589711.1 ENST00000588282.1 ENST00000589168.1 |
SYNGR2
|
synaptogyrin 2 |
| chr5_+_95998746 | 15.49 |
ENST00000508608.1
|
CAST
|
calpastatin |
| chr17_+_75136980 | 15.47 |
ENST00000585618.1
ENST00000413679.2 |
SEC14L1
|
SEC14-like 1 (S. cerevisiae) |
| chr15_-_60690163 | 15.45 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
| chr11_+_1889880 | 15.39 |
ENST00000405957.2
|
LSP1
|
lymphocyte-specific protein 1 |
| chr7_-_149470297 | 15.34 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
| chr9_-_92112953 | 15.31 |
ENST00000339861.4
ENST00000422704.2 ENST00000455551.2 |
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
| chr19_+_48828788 | 15.31 |
ENST00000594198.1
ENST00000597279.1 ENST00000593437.1 |
EMP3
|
epithelial membrane protein 3 |
| chr20_+_48807351 | 15.30 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
| chr22_+_38004832 | 15.29 |
ENST00000405147.3
ENST00000429218.1 ENST00000325180.8 ENST00000337437.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
| chr1_+_87170577 | 15.28 |
ENST00000482504.1
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1 |
| chr19_-_12777509 | 15.28 |
ENST00000221363.4
ENST00000598876.1 ENST00000456935.2 ENST00000486847.2 |
MAN2B1
|
mannosidase, alpha, class 2B, member 1 |
| chr11_-_507184 | 15.24 |
ENST00000533410.1
ENST00000354420.2 ENST00000397604.3 ENST00000531149.1 ENST00000356187.5 |
RNH1
|
ribonuclease/angiogenin inhibitor 1 |
| chr19_-_913160 | 15.18 |
ENST00000361574.5
ENST00000587975.1 |
R3HDM4
|
R3H domain containing 4 |
| chr12_-_58240470 | 15.17 |
ENST00000548823.1
ENST00000398073.2 |
CTDSP2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
| chr19_+_41305085 | 15.14 |
ENST00000303961.4
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
| chr19_-_2042065 | 15.13 |
ENST00000591588.1
ENST00000591142.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr16_-_88717423 | 15.04 |
ENST00000568278.1
ENST00000569359.1 ENST00000567174.1 |
CYBA
|
cytochrome b-245, alpha polypeptide |
| chr11_-_46142615 | 14.99 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr10_+_135192782 | 14.93 |
ENST00000480071.2
|
PAOX
|
polyamine oxidase (exo-N4-amino) |
| chr11_-_615570 | 14.91 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
| chr8_-_101734308 | 14.91 |
ENST00000519004.1
ENST00000519363.1 ENST00000520142.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr22_+_23243156 | 14.89 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
| chr17_-_79008373 | 14.89 |
ENST00000577066.1
ENST00000573167.1 |
BAIAP2-AS1
|
BAIAP2 antisense RNA 1 (head to head) |
| chr19_-_8642289 | 14.86 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
| chr15_+_90931450 | 14.83 |
ENST00000268182.5
ENST00000560738.1 ENST00000560418.1 |
IQGAP1
|
IQ motif containing GTPase activating protein 1 |
| chr2_-_61697862 | 14.81 |
ENST00000398571.2
|
USP34
|
ubiquitin specific peptidase 34 |
| chr3_+_133292759 | 14.81 |
ENST00000431519.2
|
CDV3
|
CDV3 homolog (mouse) |
| chr22_+_23264766 | 14.81 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr21_-_10990830 | 14.73 |
ENST00000361285.4
ENST00000342420.5 ENST00000328758.5 |
TPTE
|
transmembrane phosphatase with tensin homology |
| chr16_+_2802623 | 14.67 |
ENST00000576924.1
ENST00000575009.1 ENST00000576415.1 ENST00000571378.1 |
SRRM2
|
serine/arginine repetitive matrix 2 |
| chr2_-_43453734 | 14.66 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
| chr16_-_88923285 | 14.62 |
ENST00000542788.1
ENST00000569433.1 ENST00000268695.5 ENST00000568311.1 |
GALNS
|
galactosamine (N-acetyl)-6-sulfate sulfatase |
| chr19_-_10445399 | 14.50 |
ENST00000592945.1
|
ICAM3
|
intercellular adhesion molecule 3 |
| chr6_-_32157947 | 14.47 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
| chr8_-_144679532 | 14.45 |
ENST00000534380.1
ENST00000533494.1 ENST00000531218.1 ENST00000526340.1 ENST00000533204.1 ENST00000532400.1 ENST00000529516.1 ENST00000534377.1 ENST00000531621.1 ENST00000530191.1 ENST00000524900.1 ENST00000526838.1 ENST00000531931.1 ENST00000534475.1 ENST00000442189.2 ENST00000524624.1 ENST00000532596.1 ENST00000529832.1 ENST00000530306.1 ENST00000530545.1 ENST00000525261.1 ENST00000534804.1 ENST00000528303.1 ENST00000528610.1 |
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
| chr22_-_50964558 | 14.41 |
ENST00000535425.1
ENST00000439934.1 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
| chr19_+_797443 | 14.40 |
ENST00000394601.4
ENST00000589575.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
| chr19_+_41305406 | 14.39 |
ENST00000406058.2
ENST00000593726.1 |
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
| chr1_+_26856236 | 14.37 |
ENST00000374168.2
ENST00000374166.4 |
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
| chr1_+_211433275 | 14.36 |
ENST00000367005.4
|
RCOR3
|
REST corepressor 3 |
| chr13_-_41635512 | 14.36 |
ENST00000405737.2
|
ELF1
|
E74-like factor 1 (ets domain transcription factor) |
| chr19_+_48824711 | 14.35 |
ENST00000599704.1
|
EMP3
|
epithelial membrane protein 3 |
| chr10_+_82213904 | 14.32 |
ENST00000429989.3
|
TSPAN14
|
tetraspanin 14 |
| chr4_-_10118348 | 14.30 |
ENST00000502702.1
|
WDR1
|
WD repeat domain 1 |
| chr11_-_64646086 | 14.26 |
ENST00000320631.3
|
EHD1
|
EH-domain containing 1 |
| chr17_+_76165213 | 14.21 |
ENST00000590201.1
|
SYNGR2
|
synaptogyrin 2 |
| chrX_-_152989798 | 14.21 |
ENST00000441714.1
ENST00000442093.1 ENST00000429550.1 ENST00000345046.6 |
BCAP31
|
B-cell receptor-associated protein 31 |
| chr14_-_74959978 | 14.21 |
ENST00000541064.1
|
NPC2
|
Niemann-Pick disease, type C2 |
| chr1_+_118148556 | 14.20 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
| chr19_-_1652575 | 14.16 |
ENST00000587235.1
ENST00000262965.5 |
TCF3
|
transcription factor 3 |
| chr1_-_25256368 | 14.14 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
| chrX_-_107019181 | 14.10 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
| chr19_-_33793430 | 14.07 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
| chr10_+_45869652 | 14.07 |
ENST00000542434.1
ENST00000374391.2 |
ALOX5
|
arachidonate 5-lipoxygenase |
| chr22_-_50968419 | 14.04 |
ENST00000425169.1
ENST00000395680.1 ENST00000395681.1 ENST00000395678.3 ENST00000252029.3 |
TYMP
|
thymidine phosphorylase |
| chr17_-_48943706 | 14.03 |
ENST00000499247.2
|
TOB1
|
transducer of ERBB2, 1 |
| chr16_+_50776021 | 14.01 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
| chr3_-_25824925 | 13.99 |
ENST00000396649.3
ENST00000428257.1 ENST00000280700.5 |
NGLY1
|
N-glycanase 1 |
| chr6_-_33048483 | 13.97 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
| chr17_-_76778339 | 13.96 |
ENST00000591455.1
ENST00000446868.3 ENST00000361101.4 ENST00000589296.1 |
CYTH1
|
cytohesin 1 |
| chr5_+_154238149 | 13.96 |
ENST00000519430.1
ENST00000520671.1 ENST00000521583.1 ENST00000518028.1 ENST00000519404.1 ENST00000519394.1 ENST00000518775.1 |
CNOT8
|
CCR4-NOT transcription complex, subunit 8 |
| chr19_+_35606692 | 13.92 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr19_+_54694119 | 13.82 |
ENST00000456872.1
ENST00000302937.4 ENST00000429671.2 |
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
| chr13_+_111767650 | 13.74 |
ENST00000449979.1
ENST00000370623.3 |
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
| chr15_+_63796779 | 13.72 |
ENST00000561442.1
ENST00000560070.1 ENST00000540797.1 ENST00000380324.3 ENST00000268049.7 ENST00000536001.1 ENST00000539772.1 |
USP3
|
ubiquitin specific peptidase 3 |
| chr16_+_2588012 | 13.63 |
ENST00000354836.5
ENST00000389224.3 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
| chr3_+_133292851 | 13.63 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
| chr22_-_22221658 | 13.55 |
ENST00000544786.1
|
MAPK1
|
mitogen-activated protein kinase 1 |
| chr17_-_80291818 | 13.46 |
ENST00000269389.3
ENST00000581691.1 |
SECTM1
|
secreted and transmembrane 1 |
| chr14_-_21566731 | 13.40 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr1_-_15850839 | 13.40 |
ENST00000348549.5
ENST00000546424.1 |
CASP9
|
caspase 9, apoptosis-related cysteine peptidase |
| chr1_+_26606608 | 13.39 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
| chr2_+_30369859 | 13.36 |
ENST00000402003.3
|
YPEL5
|
yippee-like 5 (Drosophila) |
| chr1_+_206858328 | 13.34 |
ENST00000367103.3
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
| chr19_+_14492247 | 13.31 |
ENST00000357355.3
ENST00000592261.2 ENST00000242786.5 |
CD97
|
CD97 molecule |
| chrX_-_107018969 | 13.27 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr11_-_62380199 | 13.12 |
ENST00000419857.1
ENST00000394773.2 |
EML3
|
echinoderm microtubule associated protein like 3 |
| chr15_-_79237433 | 13.12 |
ENST00000220166.5
|
CTSH
|
cathepsin H |
| chr8_-_101734907 | 13.11 |
ENST00000318607.5
ENST00000521865.1 ENST00000520804.1 ENST00000522720.1 ENST00000521067.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr22_-_36784035 | 13.05 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
| chr7_+_2443202 | 13.04 |
ENST00000258711.6
|
CHST12
|
carbohydrate (chondroitin 4) sulfotransferase 12 |
| chr6_-_24877490 | 12.95 |
ENST00000540914.1
ENST00000378023.4 |
FAM65B
|
family with sequence similarity 65, member B |
| chr22_-_50964849 | 12.92 |
ENST00000543927.1
ENST00000423348.1 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
| chr16_+_2587998 | 12.90 |
ENST00000441549.3
ENST00000268673.7 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
| chr2_+_219264466 | 12.85 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chrX_-_1572629 | 12.79 |
ENST00000534940.1
|
ASMTL
|
acetylserotonin O-methyltransferase-like |
Network of associatons between targets according to the STRING database.
First level regulatory network of PATZ1_KLF4
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 19.4 | 58.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 19.1 | 114.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 16.0 | 16.0 | GO:0051604 | protein maturation(GO:0051604) |
| 12.8 | 38.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 12.5 | 37.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 12.5 | 49.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 11.7 | 58.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 11.3 | 11.3 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 10.9 | 54.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 10.8 | 43.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 10.6 | 53.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 10.2 | 10.2 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 9.4 | 28.3 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 9.1 | 72.7 | GO:0044351 | macropinocytosis(GO:0044351) |
| 9.0 | 27.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 8.3 | 33.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 7.5 | 7.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 7.4 | 22.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 7.4 | 7.4 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
| 7.3 | 36.3 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 7.3 | 21.8 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
| 7.2 | 28.8 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 7.1 | 28.5 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 7.0 | 21.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 7.0 | 21.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 6.8 | 27.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 6.7 | 6.7 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 6.7 | 66.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 6.5 | 19.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 6.4 | 38.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 6.3 | 44.1 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 6.0 | 18.0 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 5.9 | 53.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 5.8 | 23.3 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 5.7 | 17.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 5.7 | 45.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 5.6 | 50.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 5.6 | 56.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 5.6 | 11.2 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 5.5 | 22.0 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 5.4 | 38.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 5.4 | 21.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 5.3 | 21.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 5.2 | 15.7 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 5.2 | 5.2 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 5.2 | 15.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 5.2 | 15.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 5.1 | 10.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) |
| 5.1 | 15.3 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 5.1 | 15.3 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 5.0 | 25.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 5.0 | 34.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 5.0 | 19.8 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 4.9 | 4.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 4.7 | 47.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 4.7 | 23.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 4.7 | 18.7 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 4.6 | 23.2 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 4.6 | 13.9 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 4.6 | 13.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 4.6 | 18.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 4.6 | 9.2 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 4.6 | 36.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 4.5 | 8.9 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 4.4 | 13.3 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 4.4 | 22.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 4.4 | 48.0 | GO:0033227 | dsRNA transport(GO:0033227) |
| 4.3 | 17.3 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 4.3 | 13.0 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 4.3 | 4.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 4.3 | 77.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 4.3 | 8.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 4.3 | 12.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 4.3 | 17.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 4.2 | 21.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 4.2 | 12.5 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 4.2 | 33.4 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 4.1 | 4.1 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 4.1 | 12.4 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 4.1 | 37.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 4.1 | 12.4 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 4.1 | 103.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 4.1 | 8.2 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 4.1 | 32.7 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 4.1 | 53.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 4.1 | 12.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 4.1 | 8.1 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 4.0 | 16.2 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 4.0 | 56.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 4.0 | 4.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 4.0 | 12.1 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 4.0 | 16.0 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 4.0 | 27.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 3.9 | 15.7 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 3.9 | 11.7 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 3.9 | 11.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 3.9 | 3.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 3.9 | 19.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 3.9 | 7.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 3.8 | 11.5 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 3.8 | 7.7 | GO:0070295 | renal water absorption(GO:0070295) |
| 3.8 | 22.9 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 3.8 | 45.6 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 3.8 | 26.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 3.7 | 14.9 | GO:0001743 | optic placode formation(GO:0001743) |
| 3.7 | 18.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 3.7 | 7.4 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 3.6 | 3.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 3.6 | 10.8 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 3.6 | 21.7 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 3.6 | 75.6 | GO:0045730 | respiratory burst(GO:0045730) |
| 3.6 | 10.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 3.6 | 3.6 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
| 3.5 | 71.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 3.5 | 21.0 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 3.5 | 27.8 | GO:0046618 | drug export(GO:0046618) |
| 3.5 | 3.5 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 3.4 | 13.8 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
| 3.4 | 10.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 3.3 | 10.0 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 3.3 | 20.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 3.3 | 6.6 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 3.3 | 46.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 3.3 | 36.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 3.3 | 9.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 3.3 | 29.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 3.3 | 9.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 3.3 | 9.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 3.3 | 9.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 3.3 | 9.8 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 3.3 | 13.0 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 3.2 | 6.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 3.2 | 54.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 3.2 | 9.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 3.2 | 9.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 3.2 | 3.2 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 3.2 | 9.5 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 3.1 | 18.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 3.1 | 9.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 3.1 | 6.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 3.1 | 21.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 3.1 | 12.3 | GO:0009386 | translational attenuation(GO:0009386) |
| 3.1 | 12.2 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 3.0 | 18.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 3.0 | 3.0 | GO:0070459 | prolactin secretion(GO:0070459) |
| 3.0 | 6.1 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 3.0 | 12.1 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 3.0 | 12.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 3.0 | 20.9 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 3.0 | 6.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 3.0 | 11.9 | GO:0019086 | late viral transcription(GO:0019086) |
| 3.0 | 14.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 3.0 | 17.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 2.9 | 2.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 2.9 | 8.8 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 2.9 | 5.8 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 2.9 | 17.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 2.9 | 2.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 2.9 | 8.7 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 2.9 | 11.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 2.9 | 17.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 2.8 | 2.8 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 2.8 | 19.9 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 2.8 | 14.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 2.8 | 11.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 2.8 | 14.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 2.8 | 45.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 2.8 | 14.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 2.8 | 5.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 2.8 | 2.8 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 2.8 | 16.8 | GO:0070417 | cellular response to cold(GO:0070417) |
| 2.8 | 2.8 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 2.8 | 8.4 | GO:0048627 | myoblast development(GO:0048627) |
| 2.8 | 8.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 2.8 | 33.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 2.7 | 2.7 | GO:0014902 | myotube differentiation(GO:0014902) |
| 2.7 | 5.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 2.7 | 2.7 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 2.7 | 10.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 2.7 | 8.1 | GO:0042351 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 2.7 | 16.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 2.7 | 5.4 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 2.7 | 8.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 2.7 | 42.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 2.7 | 18.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 2.7 | 10.6 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
| 2.6 | 5.3 | GO:0034141 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 2.6 | 7.9 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 2.6 | 15.7 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 2.6 | 18.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 2.6 | 7.8 | GO:0050894 | determination of affect(GO:0050894) |
| 2.6 | 13.0 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 2.6 | 20.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 2.6 | 5.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 2.6 | 18.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 2.6 | 25.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 2.6 | 2.6 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 2.6 | 20.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 2.6 | 7.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 2.5 | 2.5 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 2.5 | 56.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 2.5 | 10.2 | GO:0016240 | autophagosome docking(GO:0016240) |
| 2.5 | 15.3 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 2.5 | 20.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 2.5 | 5.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 2.5 | 5.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 2.5 | 10.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 2.5 | 17.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 2.5 | 25.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 2.5 | 20.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 2.5 | 15.0 | GO:0048102 | autophagic cell death(GO:0048102) |
| 2.5 | 7.5 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 2.5 | 2.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 2.5 | 7.4 | GO:0044209 | AMP salvage(GO:0044209) |
| 2.5 | 19.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 2.4 | 9.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 2.4 | 4.9 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 2.4 | 4.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 2.4 | 2.4 | GO:0072319 | vesicle uncoating(GO:0072319) |
| 2.4 | 12.0 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 2.4 | 9.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 2.4 | 33.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 2.4 | 71.6 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 2.4 | 9.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 2.4 | 23.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 2.4 | 9.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 2.4 | 2.4 | GO:0001675 | acrosome assembly(GO:0001675) |
| 2.4 | 25.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 2.3 | 4.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 2.3 | 7.0 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 2.3 | 25.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 2.3 | 39.7 | GO:0030220 | platelet formation(GO:0030220) |
| 2.3 | 13.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 2.3 | 32.5 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 2.3 | 32.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 2.3 | 25.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 2.3 | 2.3 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 2.3 | 2.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 2.3 | 6.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 2.3 | 152.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 2.3 | 6.8 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 2.3 | 6.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 2.3 | 15.9 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
| 2.3 | 15.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 2.3 | 6.8 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
| 2.2 | 2.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 2.2 | 4.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 2.2 | 2.2 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 2.2 | 2.2 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 2.2 | 31.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 2.2 | 15.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 2.2 | 8.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 2.2 | 6.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 2.2 | 17.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 2.2 | 8.9 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 2.2 | 24.4 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 2.2 | 19.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 2.2 | 11.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 2.2 | 4.4 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 2.2 | 4.4 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
| 2.2 | 15.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 2.2 | 6.6 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 2.2 | 6.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 2.2 | 10.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 2.2 | 2.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 2.2 | 2.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 2.2 | 10.9 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 2.2 | 8.7 | GO:1903412 | response to bile acid(GO:1903412) |
| 2.2 | 30.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 2.2 | 19.6 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 2.2 | 69.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 2.2 | 47.4 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 2.2 | 15.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 2.1 | 2.1 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 2.1 | 4.3 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 2.1 | 6.4 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 2.1 | 8.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.1 | 4.2 | GO:1901656 | glycoside transport(GO:1901656) |
| 2.1 | 2.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 2.1 | 46.5 | GO:0071800 | podosome assembly(GO:0071800) |
| 2.1 | 6.3 | GO:0033214 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 2.1 | 4.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 2.1 | 14.7 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 2.1 | 14.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 2.1 | 6.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 2.1 | 2.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 2.1 | 6.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 2.1 | 6.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 2.1 | 16.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 2.1 | 14.5 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 2.1 | 6.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 2.1 | 6.2 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 2.1 | 4.1 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 2.1 | 6.2 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 2.1 | 8.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 2.0 | 2.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 2.0 | 32.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 2.0 | 6.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 2.0 | 6.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 2.0 | 4.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 2.0 | 10.1 | GO:0035624 | receptor transactivation(GO:0035624) |
| 2.0 | 2.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 2.0 | 6.0 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) carbon catabolite regulation of transcription(GO:0045990) |
| 2.0 | 5.9 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 2.0 | 41.4 | GO:0097503 | sialylation(GO:0097503) |
| 2.0 | 21.7 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 2.0 | 11.8 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 2.0 | 5.9 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 2.0 | 2.0 | GO:0061010 | gall bladder development(GO:0061010) |
| 2.0 | 11.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 1.9 | 17.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 1.9 | 1.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 1.9 | 7.7 | GO:0032252 | secretory granule localization(GO:0032252) |
| 1.9 | 3.9 | GO:0003285 | septum secundum development(GO:0003285) |
| 1.9 | 7.7 | GO:0014900 | muscle hyperplasia(GO:0014900) |
| 1.9 | 3.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.9 | 15.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 1.9 | 7.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 1.9 | 5.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 1.9 | 5.7 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
| 1.9 | 3.8 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 1.9 | 1.9 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 1.9 | 13.3 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 1.9 | 9.5 | GO:0042695 | thelarche(GO:0042695) development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
| 1.9 | 3.8 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 1.9 | 1.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 1.9 | 7.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 1.9 | 5.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.9 | 1.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 1.9 | 20.7 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 1.9 | 11.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 1.9 | 18.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 1.9 | 5.6 | GO:0014020 | primary neural tube formation(GO:0014020) |
| 1.9 | 9.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 1.9 | 16.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 1.9 | 1.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 1.8 | 18.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 1.8 | 7.4 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 1.8 | 16.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.8 | 38.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 1.8 | 1.8 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
| 1.8 | 3.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 1.8 | 3.7 | GO:0052255 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.8 | 7.3 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
| 1.8 | 3.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 1.8 | 16.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 1.8 | 10.9 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 1.8 | 12.8 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 1.8 | 5.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 1.8 | 14.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 1.8 | 1.8 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 1.8 | 5.4 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 1.8 | 81.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 1.8 | 7.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.8 | 1.8 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 1.8 | 3.6 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 1.8 | 17.9 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 1.8 | 3.6 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 1.8 | 1.8 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 1.8 | 30.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 1.8 | 5.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 1.8 | 21.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 1.8 | 3.5 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.8 | 7.1 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 1.8 | 7.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 1.7 | 10.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 1.7 | 1.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 1.7 | 5.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 1.7 | 1.7 | GO:0046688 | response to copper ion(GO:0046688) |
| 1.7 | 7.0 | GO:0060992 | response to fungicide(GO:0060992) |
| 1.7 | 1.7 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 1.7 | 50.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 1.7 | 6.9 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 1.7 | 12.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.7 | 3.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.7 | 5.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 1.7 | 5.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 1.7 | 8.6 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 1.7 | 3.4 | GO:0048597 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 1.7 | 5.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 1.7 | 16.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 1.7 | 5.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 1.7 | 28.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 1.7 | 3.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 1.7 | 6.7 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 1.7 | 13.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 1.7 | 10.1 | GO:0009635 | response to herbicide(GO:0009635) |
| 1.7 | 5.0 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 1.7 | 5.0 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 1.7 | 6.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 1.7 | 5.0 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 1.7 | 16.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 1.7 | 1.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 1.7 | 3.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 1.7 | 8.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 1.7 | 16.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 1.7 | 1.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 1.6 | 1.6 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 1.6 | 19.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 1.6 | 8.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 1.6 | 4.9 | GO:0002818 | intracellular defense response(GO:0002818) |
| 1.6 | 6.5 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.6 | 1.6 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.6 | 3.2 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 1.6 | 3.2 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 1.6 | 46.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 1.6 | 11.1 | GO:0045007 | depurination(GO:0045007) |
| 1.6 | 15.9 | GO:0060056 | mammary gland involution(GO:0060056) |
| 1.6 | 6.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 1.6 | 1.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 1.6 | 15.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 1.6 | 3.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 1.6 | 11.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
| 1.6 | 126.6 | GO:0016575 | histone deacetylation(GO:0016575) |
| 1.6 | 12.6 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 1.6 | 11.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 1.6 | 1.6 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 1.6 | 1.6 | GO:0002554 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 1.6 | 6.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 1.6 | 3.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.6 | 3.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 1.6 | 6.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 1.5 | 7.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 1.5 | 10.8 | GO:0070269 | pyroptosis(GO:0070269) |
| 1.5 | 1.5 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 1.5 | 1.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 1.5 | 32.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 1.5 | 30.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 1.5 | 81.7 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 1.5 | 7.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.5 | 4.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 1.5 | 4.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 1.5 | 4.6 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 1.5 | 4.6 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.5 | 1.5 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
| 1.5 | 7.6 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 1.5 | 21.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 1.5 | 6.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 1.5 | 3.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 1.5 | 7.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 1.5 | 3.0 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 1.5 | 11.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 1.5 | 1.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 1.5 | 3.0 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
| 1.5 | 2.9 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
| 1.5 | 1.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.5 | 5.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 1.5 | 10.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 1.5 | 10.2 | GO:0030091 | protein repair(GO:0030091) |
| 1.5 | 1.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 1.5 | 1.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 1.5 | 2.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 1.5 | 105.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 1.5 | 10.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 1.4 | 13.0 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 1.4 | 2.9 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 1.4 | 4.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 1.4 | 11.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 1.4 | 4.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 1.4 | 4.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 1.4 | 1.4 | GO:0052040 | negative regulation by symbiont of host apoptotic process(GO:0033668) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 1.4 | 8.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.4 | 1.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
| 1.4 | 14.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 1.4 | 4.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.4 | 5.7 | GO:0071472 | cellular response to salt stress(GO:0071472) |
| 1.4 | 21.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 1.4 | 5.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 1.4 | 4.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.4 | 7.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 1.4 | 5.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 1.4 | 7.0 | GO:0021759 | globus pallidus development(GO:0021759) |
| 1.4 | 7.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 1.4 | 12.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 1.4 | 2.8 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.4 | 4.2 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) positive regulation of brown fat cell differentiation(GO:0090336) |
| 1.4 | 16.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 1.4 | 5.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 1.4 | 1.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.4 | 4.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.4 | 4.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 1.4 | 9.6 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 1.4 | 4.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 1.4 | 5.5 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 1.4 | 1.4 | GO:0051458 | corticotropin secretion(GO:0051458) |
| 1.4 | 1.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 1.4 | 2.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 1.4 | 21.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 1.4 | 32.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 1.4 | 5.4 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 1.4 | 1.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 1.3 | 2.7 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 1.3 | 16.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.3 | 9.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.3 | 6.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 1.3 | 1.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
| 1.3 | 1.3 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
| 1.3 | 4.0 | GO:0080009 | mRNA methylation(GO:0080009) |
| 1.3 | 2.7 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 1.3 | 4.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 1.3 | 9.2 | GO:0070487 | monocyte aggregation(GO:0070487) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.3 | 13.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 1.3 | 5.2 | GO:0003335 | corneocyte development(GO:0003335) |
| 1.3 | 1.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.3 | 11.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 1.3 | 1.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 1.3 | 9.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 1.3 | 2.5 | GO:0002384 | hepatic immune response(GO:0002384) |
| 1.3 | 3.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.3 | 10.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 1.3 | 15.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 1.3 | 6.3 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.3 | 1.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.3 | 2.5 | GO:0043416 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 1.3 | 5.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 1.3 | 18.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 1.3 | 6.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 1.2 | 6.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.2 | 3.7 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 1.2 | 7.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 1.2 | 2.5 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 1.2 | 2.5 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 1.2 | 2.5 | GO:0055099 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
| 1.2 | 56.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 1.2 | 29.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 1.2 | 3.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 1.2 | 4.9 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 1.2 | 71.8 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 1.2 | 3.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 1.2 | 3.6 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 1.2 | 3.6 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 1.2 | 4.8 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 1.2 | 1.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 1.2 | 1.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 1.2 | 2.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 1.2 | 7.2 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
| 1.2 | 1.2 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 1.2 | 6.0 | GO:0015862 | uridine transport(GO:0015862) |
| 1.2 | 2.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 1.2 | 3.6 | GO:1905204 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 1.2 | 17.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 1.2 | 2.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 1.2 | 26.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 1.2 | 9.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 1.2 | 5.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 1.2 | 3.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.2 | 2.3 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 1.2 | 2.3 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 1.2 | 25.7 | GO:0043574 | peroxisomal transport(GO:0043574) |
| 1.2 | 16.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 1.2 | 3.5 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 1.2 | 1.2 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 1.2 | 3.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 1.2 | 2.3 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 1.2 | 2.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 1.2 | 1.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 1.2 | 1.2 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 1.2 | 3.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 1.2 | 10.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 1.1 | 4.6 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.1 | 8.0 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 1.1 | 6.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 1.1 | 3.4 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.1 | 4.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 1.1 | 2.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 1.1 | 2.3 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 1.1 | 1.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 1.1 | 11.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 1.1 | 1.1 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
| 1.1 | 2.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 1.1 | 11.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 1.1 | 37.1 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 1.1 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.1 | 2.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.1 | 4.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 1.1 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 1.1 | 3.4 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 1.1 | 15.6 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 1.1 | 5.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 1.1 | 81.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 1.1 | 6.7 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 1.1 | 4.4 | GO:1901098 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
| 1.1 | 1.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 1.1 | 5.5 | GO:0051451 | myoblast migration(GO:0051451) |
| 1.1 | 2.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
| 1.1 | 1.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 1.1 | 2.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 1.1 | 4.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 1.1 | 6.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.1 | 2.2 | GO:0050755 | chemokine metabolic process(GO:0050755) |
| 1.1 | 1.1 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 1.1 | 2.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 1.1 | 10.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 1.1 | 1.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 1.1 | 4.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 1.1 | 1.1 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 1.1 | 3.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 1.1 | 5.4 | GO:0035965 | cardiolipin metabolic process(GO:0032048) cardiolipin acyl-chain remodeling(GO:0035965) |
| 1.1 | 5.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 1.1 | 1.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 1.1 | 3.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 1.1 | 6.4 | GO:0015811 | L-cystine transport(GO:0015811) |
| 1.1 | 4.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.1 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 1.1 | 3.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 1.1 | 2.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 1.1 | 1.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
| 1.1 | 14.7 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 1.1 | 2.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 1.0 | 17.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 1.0 | 26.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 1.0 | 12.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 1.0 | 6.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 1.0 | 6.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
| 1.0 | 14.4 | GO:0050779 | RNA destabilization(GO:0050779) |
| 1.0 | 2.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 1.0 | 23.5 | GO:0050832 | defense response to fungus(GO:0050832) |
| 1.0 | 3.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 1.0 | 2.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
| 1.0 | 5.1 | GO:0090009 | primitive streak formation(GO:0090009) |
| 1.0 | 18.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 1.0 | 13.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 1.0 | 22.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 1.0 | 3.0 | GO:0002702 | positive regulation of production of molecular mediator of immune response(GO:0002702) |
| 1.0 | 4.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 1.0 | 1.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 1.0 | 7.0 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
| 1.0 | 12.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) proton-transporting two-sector ATPase complex assembly(GO:0070071) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 1.0 | 1.0 | GO:1990523 | bone regeneration(GO:1990523) |
| 1.0 | 2.0 | GO:0048539 | bone marrow development(GO:0048539) |
| 1.0 | 5.0 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 1.0 | 49.9 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 1.0 | 1.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 1.0 | 6.9 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 1.0 | 7.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 1.0 | 6.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 1.0 | 1.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 1.0 | 2.0 | GO:0046677 | response to antibiotic(GO:0046677) |
| 1.0 | 1.0 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 1.0 | 2.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.0 | 2.0 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
| 1.0 | 2.9 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 1.0 | 8.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 1.0 | 8.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 1.0 | 1.0 | GO:0044805 | late nucleophagy(GO:0044805) |
| 1.0 | 4.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 1.0 | 2.9 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 1.0 | 12.5 | GO:0097421 | liver regeneration(GO:0097421) |
| 1.0 | 1.9 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 1.0 | 8.6 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
| 1.0 | 8.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 1.0 | 1.0 | GO:0072079 | nephron tubule formation(GO:0072079) |
| 1.0 | 3.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 1.0 | 3.8 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 1.0 | 9.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 1.0 | 2.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.9 | 0.9 | GO:0061525 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) hindgut development(GO:0061525) |
| 0.9 | 1.9 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.9 | 1.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.9 | 3.8 | GO:0010193 | response to ozone(GO:0010193) |
| 0.9 | 8.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.9 | 49.9 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.9 | 2.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.9 | 3.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.9 | 3.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.9 | 0.9 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.9 | 8.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.9 | 5.6 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.9 | 6.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.9 | 5.6 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.9 | 1.9 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.9 | 18.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.9 | 8.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.9 | 0.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.9 | 3.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.9 | 2.8 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.9 | 16.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.9 | 0.9 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.9 | 12.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.9 | 18.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.9 | 3.6 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.9 | 3.6 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.9 | 0.9 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
| 0.9 | 36.0 | GO:1901998 | toxin transport(GO:1901998) |
| 0.9 | 1.8 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.9 | 2.7 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.9 | 7.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.9 | 17.9 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.9 | 9.8 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.9 | 7.1 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.9 | 0.9 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.9 | 3.5 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.9 | 5.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.9 | 8.9 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.9 | 1.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.9 | 2.6 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.9 | 4.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.9 | 17.5 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.9 | 17.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.9 | 0.9 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
| 0.9 | 7.9 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.9 | 1.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
| 0.9 | 1.7 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 0.9 | 6.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.9 | 4.3 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
| 0.9 | 2.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.9 | 8.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.9 | 2.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.9 | 3.5 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.9 | 4.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.9 | 0.9 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.9 | 4.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.9 | 0.9 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.9 | 5.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.8 | 3.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.8 | 1.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.8 | 5.9 | GO:0060956 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
| 0.8 | 1.7 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.8 | 5.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.8 | 0.8 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.8 | 4.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.8 | 1.7 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
| 0.8 | 30.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
| 0.8 | 0.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.8 | 1.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.8 | 11.6 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.8 | 6.6 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.8 | 7.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.8 | 3.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.8 | 1.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.8 | 2.5 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.8 | 1.6 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) |
| 0.8 | 3.3 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.8 | 2.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.8 | 6.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.8 | 144.7 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.8 | 2.5 | GO:0070265 | necrotic cell death(GO:0070265) |
| 0.8 | 8.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.8 | 1.6 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.8 | 4.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.8 | 0.8 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.8 | 1.6 | GO:0060023 | soft palate development(GO:0060023) |
| 0.8 | 1.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.8 | 4.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.8 | 0.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.8 | 4.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.8 | 3.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.8 | 7.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.8 | 1.6 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
| 0.8 | 2.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.8 | 14.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
| 0.8 | 4.0 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.8 | 2.4 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.8 | 1.6 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.8 | 2.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.8 | 2.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.8 | 1.6 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.8 | 6.3 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.8 | 8.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.8 | 3.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.8 | 2.3 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.8 | 2.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.8 | 6.2 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.8 | 3.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.8 | 1.6 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.8 | 4.7 | GO:0015791 | polyol transport(GO:0015791) |
| 0.8 | 6.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.8 | 1.5 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.8 | 2.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.8 | 3.1 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.8 | 6.9 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.8 | 2.3 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.8 | 4.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.8 | 0.8 | GO:0042026 | protein refolding(GO:0042026) |
| 0.8 | 3.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.8 | 1.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.8 | 2.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.8 | 4.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.8 | 3.8 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.8 | 6.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.8 | 5.3 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.8 | 1.5 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
| 0.7 | 4.5 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.7 | 4.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.7 | 3.0 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.7 | 2.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.7 | 3.0 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.7 | 6.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.7 | 0.7 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 0.7 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.7 | 17.0 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.7 | 2.9 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.7 | 4.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.7 | 3.7 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.7 | 13.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.7 | 17.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.7 | 1.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
| 0.7 | 1.5 | GO:0002537 | nitric oxide production involved in inflammatory response(GO:0002537) |
| 0.7 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.7 | 12.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.7 | 15.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.7 | 2.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.7 | 1.4 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.7 | 0.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.7 | 1.4 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.7 | 3.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.7 | 1.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.7 | 0.7 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.7 | 1.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.7 | 8.5 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.7 | 1.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.7 | 1.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.7 | 3.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.7 | 3.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.7 | 9.2 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.7 | 20.5 | GO:0050764 | regulation of phagocytosis(GO:0050764) |
| 0.7 | 10.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.7 | 1.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.7 | 4.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 | 2.8 | GO:0050893 | sensory processing(GO:0050893) |
| 0.7 | 99.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.7 | 4.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.7 | 10.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.7 | 7.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.7 | 0.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.7 | 2.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.7 | 4.2 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.7 | 0.7 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.7 | 3.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.7 | 8.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.7 | 4.8 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.7 | 4.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.7 | 10.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.7 | 2.0 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.7 | 2.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.7 | 2.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.7 | 4.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.7 | 4.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.7 | 0.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.7 | 4.0 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.7 | 1.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.7 | 3.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.7 | 17.2 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.7 | 1.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.7 | 3.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.7 | 2.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.7 | 13.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.7 | 3.3 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.7 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.7 | 17.7 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.7 | 1.3 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.7 | 2.6 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.6 | 2.6 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.6 | 1.9 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.6 | 3.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.6 | 0.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.6 | 3.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.6 | 1.3 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.6 | 3.9 | GO:0097009 | energy homeostasis(GO:0097009) |
| 0.6 | 1.9 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.6 | 1.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.6 | 1.3 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.6 | 4.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.6 | 7.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.6 | 1.9 | GO:1905214 | regulation of RNA binding(GO:1905214) |
| 0.6 | 3.8 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.6 | 1.3 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
| 0.6 | 1.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.6 | 3.8 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.6 | 10.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.6 | 6.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.6 | 1.3 | GO:0060438 | trachea development(GO:0060438) |
| 0.6 | 0.6 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.6 | 1.3 | GO:0048103 | somatic stem cell division(GO:0048103) |
| 0.6 | 0.6 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
| 0.6 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.6 | 1.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.6 | 6.8 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) |
| 0.6 | 1.9 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.6 | 1.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.6 | 1.9 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.6 | 0.6 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.6 | 3.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.6 | 6.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.6 | 0.6 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.6 | 6.1 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.6 | 5.5 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.6 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.6 | 12.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.6 | 0.6 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.6 | 1.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.6 | 3.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.6 | 1.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.6 | 1.8 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.6 | 1.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.6 | 4.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.6 | 4.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.6 | 1.8 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.6 | 0.6 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.6 | 0.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.6 | 3.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.6 | 7.1 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.6 | 0.6 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.6 | 1.8 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.6 | 0.6 | GO:0060592 | His-Purkinje system development(GO:0003164) bundle of His development(GO:0003166) mammary gland formation(GO:0060592) |
| 0.6 | 1.8 | GO:0015074 | DNA integration(GO:0015074) |
| 0.6 | 0.6 | GO:0046822 | regulation of nucleocytoplasmic transport(GO:0046822) |
| 0.6 | 2.3 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.6 | 1.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.6 | 2.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.6 | 22.0 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.6 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.6 | 23.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.6 | 0.6 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.6 | 1.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.6 | 13.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.6 | 10.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.6 | 15.4 | GO:0033198 | response to ATP(GO:0033198) |
| 0.6 | 1.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.6 | 1.1 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.6 | 17.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.6 | 2.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.6 | 9.1 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.6 | 2.8 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.6 | 11.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 | 1.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.6 | 2.8 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.6 | 1.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.6 | 1.1 | GO:0044782 | cilium organization(GO:0044782) |
| 0.6 | 8.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.6 | 3.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.6 | 2.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |
| 0.6 | 9.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.6 | 2.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.5 | 1.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
| 0.5 | 2.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.5 | 2.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.5 | 2.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.5 | 18.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.5 | 26.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.5 | 5.4 | GO:0003341 | cilium movement(GO:0003341) |
| 0.5 | 1.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.5 | 0.5 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
| 0.5 | 1.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.5 | 3.8 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.5 | 1.1 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.5 | 2.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.5 | 0.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.5 | 7.5 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.5 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) Spemann organizer formation(GO:0060061) |
| 0.5 | 17.0 | GO:0030217 | T cell differentiation(GO:0030217) |
| 0.5 | 1.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.5 | 1.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.5 | 0.5 | GO:0061515 | myeloid cell development(GO:0061515) |
| 0.5 | 3.2 | GO:0016246 | RNA interference(GO:0016246) |
| 0.5 | 10.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.5 | 0.5 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
| 0.5 | 7.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.5 | 2.1 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.5 | 3.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.5 | 6.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.5 | 1.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.5 | 7.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.5 | 6.3 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
| 0.5 | 0.5 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.5 | 2.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.5 | 1.6 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) modification by host of symbiont molecular function(GO:0052428) |
| 0.5 | 1.6 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.5 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.5 | 0.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.5 | 0.5 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.5 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.5 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.5 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.5 | 2.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.5 | 3.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.5 | 0.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.5 | 7.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.5 | 0.5 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.5 | 2.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.5 | 2.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.5 | 20.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.5 | 9.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.5 | 0.5 | GO:0046078 | dUMP metabolic process(GO:0046078) |
| 0.5 | 2.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.5 | 5.0 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.5 | 3.0 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
| 0.5 | 1.0 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.5 | 13.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.5 | 2.0 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.5 | 7.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.5 | 1.0 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.5 | 3.4 | GO:0048536 | spleen development(GO:0048536) |
| 0.5 | 1.5 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.5 | 3.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.5 | 1.5 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.5 | 1.4 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.5 | 1.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.5 | 2.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.5 | 3.8 | GO:0021794 | thalamus development(GO:0021794) |
| 0.5 | 4.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.5 | 2.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.5 | 3.8 | GO:0015886 | heme transport(GO:0015886) |
| 0.5 | 1.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.5 | 2.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
| 0.5 | 0.9 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.5 | 0.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.5 | 0.9 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.5 | 3.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.5 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.5 | 5.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.5 | 0.5 | GO:0010171 | body morphogenesis(GO:0010171) |
| 0.5 | 1.4 | GO:0090260 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.5 | 1.9 | GO:0008356 | asymmetric cell division(GO:0008356) |
| 0.5 | 8.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.5 | 9.3 | GO:0030317 | sperm motility(GO:0030317) |
| 0.5 | 0.5 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
| 0.5 | 6.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.5 | 0.5 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
| 0.5 | 30.0 | GO:0007286 | spermatid development(GO:0007286) |
| 0.5 | 3.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.5 | 1.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.5 | 0.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.5 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.5 | 1.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.5 | 1.8 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.5 | 0.5 | GO:0070486 | leukocyte aggregation(GO:0070486) |
| 0.5 | 2.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.5 | 72.3 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.5 | 112.0 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.4 | 1.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
| 0.4 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.4 | 1.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.4 | 1.8 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
| 0.4 | 2.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.4 | 0.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.4 | 2.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.4 | 1.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.4 | 6.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.4 | 2.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
| 0.4 | 0.9 | GO:2001225 | regulation of chloride transport(GO:2001225) |
| 0.4 | 0.9 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.4 | 1.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.4 | 1.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.4 | 1.7 | GO:0042335 | cuticle development(GO:0042335) |
| 0.4 | 1.7 | GO:0022605 | oogenesis stage(GO:0022605) |
| 0.4 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.4 | 3.9 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.4 | 0.9 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
| 0.4 | 3.0 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
| 0.4 | 1.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.4 | 6.5 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.4 | 1.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.4 | 3.4 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.4 | 0.4 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.4 | 0.4 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 0.4 | 1.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.4 | 5.4 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.4 | 1.7 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
| 0.4 | 1.3 | GO:0072176 | nephric duct development(GO:0072176) |
| 0.4 | 2.5 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.4 | 9.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.4 | 30.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.4 | 6.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 | 0.4 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.4 | 2.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.4 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.4 | 0.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.4 | 8.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
| 0.4 | 7.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.4 | 7.2 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.4 | 1.6 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.4 | 6.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.4 | 1.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.4 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.4 | 25.2 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.4 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.4 | 1.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.4 | 7.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.4 | 3.5 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.4 | 0.4 | GO:0060765 | regulation of intracellular steroid hormone receptor signaling pathway(GO:0033143) regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.4 | 3.1 | GO:1900076 | regulation of cellular response to insulin stimulus(GO:1900076) |
| 0.4 | 3.5 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.4 | 5.8 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.4 | 4.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.4 | 13.5 | GO:0006402 | mRNA catabolic process(GO:0006402) |
| 0.4 | 0.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.4 | 0.8 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.4 | 2.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.4 | 1.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.4 | 1.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.4 | 9.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 | 1.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.4 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.4 | 1.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.4 | 3.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.4 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.4 | 0.4 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.4 | 1.5 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
| 0.4 | 8.6 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
| 0.4 | 4.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.4 | 1.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.4 | 8.9 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
| 0.4 | 1.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 | 1.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.4 | 2.9 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.4 | 9.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.4 | 0.4 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.4 | 0.4 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) regulation of glutamate metabolic process(GO:2000211) |
| 0.4 | 0.7 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.4 | 1.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.4 | 4.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.4 | 2.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
| 0.4 | 2.9 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.4 | 1.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.4 | 0.7 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.4 | 1.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.4 | 2.8 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.4 | 1.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.4 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.3 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.3 | 1.7 | GO:0060021 | palate development(GO:0060021) |
| 0.3 | 2.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.3 | 9.7 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.3 | 1.7 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.3 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.3 | 1.7 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.3 | 0.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.3 | 1.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.3 | 1.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.3 | 89.2 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.3 | 0.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.3 | 0.3 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
| 0.3 | 11.7 | GO:0051250 | negative regulation of lymphocyte activation(GO:0051250) |
| 0.3 | 1.0 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.3 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 | 2.0 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.3 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.3 | 0.7 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.3 | 0.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 | 1.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.3 | 2.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.3 | 3.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.3 | 4.9 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.3 | 0.6 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.3 | 0.6 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.3 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.3 | 0.6 | GO:0030238 | male sex determination(GO:0030238) |
| 0.3 | 0.3 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.3 | 1.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.3 | 0.6 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.3 | 0.6 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.3 | 0.3 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 | 6.6 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.3 | 4.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.3 | 0.9 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
| 0.3 | 8.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
| 0.3 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 1.5 | GO:0097384 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) cellular lipid biosynthetic process(GO:0097384) |
| 0.3 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 0.9 | GO:0072114 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) pronephros morphogenesis(GO:0072114) |
| 0.3 | 3.9 | GO:0006401 | RNA catabolic process(GO:0006401) |
| 0.3 | 1.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.3 | 1.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.3 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.3 | 1.5 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.3 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.3 | 3.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.3 | 0.6 | GO:0017145 | stem cell division(GO:0017145) |
| 0.3 | 6.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.3 | 6.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.3 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 | 1.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.3 | 3.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.3 | 2.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.3 | 3.9 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.3 | 1.5 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.3 | 1.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.3 | 1.8 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.3 | 0.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.3 | 10.6 | GO:0043487 | regulation of RNA stability(GO:0043487) |
| 0.3 | 0.3 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.3 | 1.2 | GO:0034331 | cell junction maintenance(GO:0034331) |
| 0.3 | 1.7 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.3 | 0.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.3 | 1.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.3 | 1.1 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.3 | 0.9 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.3 | 0.3 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.3 | 2.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.3 | 0.3 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
| 0.3 | 1.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.3 | 0.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.3 | 0.3 | GO:0034695 | response to prostaglandin E(GO:0034695) |
| 0.3 | 0.6 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.3 | 2.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
| 0.3 | 0.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
| 0.3 | 7.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.3 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 | 2.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.3 | 0.8 | GO:0071635 | negative regulation of transforming growth factor beta2 production(GO:0032912) negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.3 | 0.8 | GO:0090316 | positive regulation of intracellular protein transport(GO:0090316) |
| 0.3 | 4.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.3 | 18.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.3 | 2.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 | 1.6 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.3 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.3 | 0.5 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.3 | 0.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.3 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 | 0.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 2.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.3 | 0.3 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.3 | 1.0 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.3 | 0.5 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.3 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.2 | 0.5 | GO:0001525 | angiogenesis(GO:0001525) |
| 0.2 | 1.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.2 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 | 1.0 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.2 | 4.7 | GO:0019827 | stem cell population maintenance(GO:0019827) |
| 0.2 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.2 | 1.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 | 0.2 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.2 | 0.2 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.2 | 0.7 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.2 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 3.7 | GO:0042113 | B cell activation(GO:0042113) |
| 0.2 | 1.0 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 | 1.0 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.2 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 1.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
| 0.2 | 4.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.2 | 1.2 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
| 0.2 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.2 | 0.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.2 | 1.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 | 0.7 | GO:0018201 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.2 | 2.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.2 | 4.2 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.2 | 0.9 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.2 | 4.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.2 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.2 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 2.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.2 | 5.9 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.2 | 0.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.2 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.2 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.2 | 0.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.2 | 1.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.2 | 1.9 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.2 | 0.8 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 | 0.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 2.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 | 3.7 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 1.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 | 0.6 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.2 | 0.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.2 | 0.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 | 1.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.2 | 1.7 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
| 0.2 | 14.3 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.2 | 2.1 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
| 0.2 | 1.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.2 | 0.4 | GO:0001541 | ovarian follicle development(GO:0001541) |
| 0.2 | 0.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
| 0.2 | 0.4 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.2 | 0.9 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.2 | 2.6 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.2 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.2 | 0.7 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
| 0.2 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.2 | 0.5 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
| 0.2 | 4.8 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
| 0.2 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.2 | 2.6 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.2 | 0.7 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
| 0.2 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.2 | 1.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.2 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.2 | 0.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.2 | 0.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 0.8 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.2 | 0.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.2 | 1.0 | GO:0048265 | response to pain(GO:0048265) |
| 0.2 | 2.6 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.2 | 3.3 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.2 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 | 2.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.2 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 0.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.2 | 2.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.2 | 0.6 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
| 0.2 | 0.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.2 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.2 | 0.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 | 1.8 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.1 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.7 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 | 1.0 | GO:0046683 | response to organophosphorus(GO:0046683) |
| 0.1 | 0.1 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
| 0.1 | 1.3 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 0.7 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.1 | 3.4 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.1 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 | 0.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
| 0.1 | 0.3 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 | 0.4 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
| 0.1 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 2.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 | 0.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 | 2.6 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.1 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 4.1 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.1 | 0.8 | GO:0016137 | glycoside metabolic process(GO:0016137) |
| 0.1 | 0.3 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
| 0.1 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 | 0.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.9 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.1 | 0.4 | GO:0006949 | syncytium formation(GO:0006949) |
| 0.1 | 0.4 | GO:0001906 | cell killing(GO:0001906) |
| 0.1 | 2.2 | GO:0051216 | cartilage development(GO:0051216) |
| 0.1 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.7 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
| 0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 6.9 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.1 | GO:0009446 | putrescine metabolic process(GO:0009445) putrescine biosynthetic process(GO:0009446) |
| 0.1 | 0.8 | GO:0030239 | myofibril assembly(GO:0030239) |
| 0.1 | 0.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 0.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.1 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 4.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 4.9 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 | 0.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 1.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 0.3 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 | 0.6 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 | 0.5 | GO:0090342 | regulation of cell aging(GO:0090342) |
| 0.1 | 4.8 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
| 0.1 | 1.1 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.1 | 0.2 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.1 | 1.4 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.1 | 0.1 | GO:0034184 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 0.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.1 | 0.7 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.1 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 0.3 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.3 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 | 0.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.1 | 0.2 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.1 | 0.3 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
| 0.1 | 3.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.1 | 0.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.1 | 0.2 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
| 0.1 | 0.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
| 0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 | 0.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 1.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.1 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 0.7 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 0.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.1 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.1 | 0.1 | GO:0097056 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 | 1.0 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 | 0.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.2 | GO:0090398 | cellular senescence(GO:0090398) |
| 0.1 | 1.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 0.5 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 | 0.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.2 | GO:0010092 | specification of organ identity(GO:0010092) |
| 0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
| 0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
| 0.1 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 17.5 | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter(GO:0000122) |
| 0.1 | 0.1 | GO:0098868 | bone growth(GO:0098868) |
| 0.1 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.1 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 | 4.1 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.0 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.0 | 0.0 | GO:0010469 | regulation of receptor activity(GO:0010469) regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.0 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.0 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.0 | 0.2 | GO:0050704 | regulation of interleukin-1 secretion(GO:0050704) |
| 0.0 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.0 | 0.0 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
| 0.0 | 0.1 | GO:0001503 | ossification(GO:0001503) |
| 0.0 | 0.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.0 | 0.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
| 0.0 | 0.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
| 0.0 | 0.3 | GO:0006582 | melanin metabolic process(GO:0006582) |
| 0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.0 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.1 | GO:2000849 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 | 0.0 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
| 0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.0 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.0 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.0 | 0.0 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.0 | 0.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.0 | 0.1 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.0 | 0.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.0 | 0.1 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
| 0.0 | 0.6 | GO:0016573 | histone acetylation(GO:0016573) |
| 0.0 | 0.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.0 | 0.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
| 0.0 | 0.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 0.0 | GO:1902074 | response to salt(GO:1902074) |
| 0.0 | 0.0 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
| 0.0 | 0.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.0 | 0.0 | GO:0006476 | protein deacetylation(GO:0006476) |
| 0.0 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 0.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 0.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.8 | 38.4 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 8.8 | 35.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 8.5 | 42.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 7.4 | 29.5 | GO:0043293 | apoptosome(GO:0043293) |
| 7.0 | 21.0 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 6.9 | 27.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 6.8 | 20.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 6.0 | 30.0 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 5.9 | 41.0 | GO:0071203 | WASH complex(GO:0071203) |
| 5.8 | 23.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 5.6 | 22.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 5.6 | 33.4 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 5.5 | 27.6 | GO:0036398 | TCR signalosome(GO:0036398) |
| 5.4 | 43.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 5.4 | 32.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 5.4 | 42.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 5.3 | 37.1 | GO:0001520 | outer dense fiber(GO:0001520) |
| 5.0 | 29.9 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 5.0 | 29.7 | GO:0001740 | Barr body(GO:0001740) |
| 4.9 | 54.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 4.9 | 14.8 | GO:0031523 | Myb complex(GO:0031523) |
| 4.9 | 4.9 | GO:0030686 | 90S preribosome(GO:0030686) |
| 4.9 | 53.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 4.8 | 42.9 | GO:0044194 | cytolytic granule(GO:0044194) |
| 4.7 | 14.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 4.7 | 33.1 | GO:0072487 | MSL complex(GO:0072487) |
| 4.7 | 28.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 4.7 | 56.1 | GO:0005642 | annulate lamellae(GO:0005642) |
| 4.7 | 32.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 4.6 | 18.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 4.5 | 76.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 4.5 | 22.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 4.5 | 13.4 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 4.4 | 79.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 4.3 | 12.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 4.2 | 8.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 4.2 | 20.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 4.1 | 12.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 4.0 | 39.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 4.0 | 7.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 3.9 | 66.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 3.9 | 27.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 3.8 | 15.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 3.8 | 33.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 3.7 | 55.9 | GO:0000124 | SAGA complex(GO:0000124) |
| 3.7 | 18.5 | GO:0071797 | LUBAC complex(GO:0071797) |
| 3.7 | 88.4 | GO:0005861 | troponin complex(GO:0005861) |
| 3.6 | 10.8 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 3.3 | 19.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 3.3 | 35.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 3.2 | 25.5 | GO:0000322 | storage vacuole(GO:0000322) |
| 3.1 | 9.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 3.1 | 145.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 3.1 | 9.2 | GO:1903349 | omegasome membrane(GO:1903349) |
| 3.1 | 12.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 3.0 | 17.8 | GO:0042825 | TAP complex(GO:0042825) |
| 2.9 | 8.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 2.8 | 19.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 2.8 | 16.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 2.8 | 16.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 2.7 | 49.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 2.7 | 16.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 2.7 | 21.8 | GO:0032009 | early phagosome(GO:0032009) |
| 2.7 | 13.6 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 2.6 | 7.9 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 2.6 | 10.4 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 2.6 | 2.6 | GO:0044308 | axonal spine(GO:0044308) |
| 2.6 | 18.0 | GO:0032584 | growth cone membrane(GO:0032584) |
| 2.5 | 7.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 2.5 | 12.4 | GO:0032021 | NELF complex(GO:0032021) |
| 2.5 | 24.7 | GO:0071953 | elastic fiber(GO:0071953) |
| 2.4 | 48.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 2.3 | 18.8 | GO:0032059 | bleb(GO:0032059) |
| 2.3 | 48.7 | GO:0042611 | MHC protein complex(GO:0042611) |
| 2.3 | 4.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 2.3 | 22.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 2.2 | 6.5 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 2.2 | 10.9 | GO:0001652 | granular component(GO:0001652) |
| 2.1 | 10.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 2.1 | 10.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 2.1 | 6.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 2.1 | 8.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 2.1 | 41.3 | GO:0030056 | hemidesmosome(GO:0030056) |
| 2.1 | 26.7 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 2.0 | 12.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 2.0 | 36.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 2.0 | 13.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 2.0 | 3.9 | GO:0045298 | tubulin complex(GO:0045298) |
| 2.0 | 5.9 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.9 | 5.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 1.9 | 5.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 1.9 | 17.1 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.9 | 9.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 1.9 | 1.9 | GO:0042587 | glycogen granule(GO:0042587) |
| 1.9 | 13.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 1.9 | 5.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.8 | 191.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 1.8 | 5.4 | GO:0000805 | X chromosome(GO:0000805) |
| 1.8 | 32.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 1.8 | 3.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 1.8 | 1.8 | GO:0035061 | interchromatin granule(GO:0035061) |
| 1.8 | 12.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 1.8 | 253.0 | GO:0016605 | PML body(GO:0016605) |
| 1.8 | 5.3 | GO:0061673 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
| 1.7 | 5.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 1.7 | 10.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 1.7 | 6.7 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.7 | 5.0 | GO:0097179 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) protease inhibitor complex(GO:0097179) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 1.7 | 14.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 1.6 | 8.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 1.6 | 4.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 1.6 | 14.3 | GO:0032039 | integrator complex(GO:0032039) |
| 1.6 | 1.6 | GO:0097427 | microtubule bundle(GO:0097427) |
| 1.6 | 105.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 1.5 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
| 1.5 | 22.9 | GO:0000346 | transcription export complex(GO:0000346) |
| 1.5 | 3.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 1.5 | 6.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 1.5 | 8.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 1.5 | 13.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 1.5 | 2.9 | GO:0030057 | desmosome(GO:0030057) |
| 1.5 | 5.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 1.5 | 23.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 1.4 | 56.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 1.4 | 9.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 1.4 | 4.2 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 1.4 | 5.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.4 | 28.8 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 1.4 | 63.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 1.4 | 241.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 1.4 | 4.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 1.4 | 8.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 1.3 | 123.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 1.3 | 8.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.3 | 9.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 1.3 | 4.0 | GO:0001939 | female pronucleus(GO:0001939) |
| 1.3 | 11.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 1.3 | 6.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 1.3 | 11.5 | GO:0097413 | Lewy body(GO:0097413) |
| 1.3 | 25.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 1.3 | 22.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 1.3 | 21.3 | GO:0031932 | TORC2 complex(GO:0031932) |
| 1.2 | 26.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 1.2 | 12.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 1.2 | 110.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 1.2 | 12.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 1.2 | 3.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 1.2 | 8.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 1.2 | 4.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 1.2 | 10.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 1.2 | 3.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 1.2 | 8.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 1.2 | 13.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 1.2 | 1.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 1.2 | 7.0 | GO:0044754 | autolysosome(GO:0044754) |
| 1.2 | 5.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.2 | 4.6 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 1.2 | 4.6 | GO:0090543 | Flemming body(GO:0090543) |
| 1.1 | 13.8 | GO:0001741 | XY body(GO:0001741) |
| 1.1 | 12.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 1.1 | 1.1 | GO:0031143 | pseudopodium(GO:0031143) |
| 1.1 | 2.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 1.1 | 4.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 1.1 | 5.5 | GO:0032449 | CBM complex(GO:0032449) |
| 1.1 | 4.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 1.1 | 3.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 1.1 | 6.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 1.1 | 3.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 1.1 | 5.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.1 | 3.2 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 1.1 | 4.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 1.1 | 12.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 1.1 | 4.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 1.0 | 8.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 1.0 | 13.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 1.0 | 4.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 1.0 | 5.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.0 | 3.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 1.0 | 14.3 | GO:0035102 | PRC1 complex(GO:0035102) |
| 1.0 | 7.1 | GO:0097361 | CIA complex(GO:0097361) |
| 1.0 | 17.1 | GO:0097225 | sperm midpiece(GO:0097225) |
| 1.0 | 1.0 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 1.0 | 7.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 1.0 | 27.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 1.0 | 4.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 1.0 | 4.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 1.0 | 33.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 1.0 | 15.8 | GO:0035861 | site of double-strand break(GO:0035861) |
| 1.0 | 4.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 1.0 | 4.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 1.0 | 3.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 1.0 | 4.9 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 1.0 | 8.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 1.0 | 3.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 1.0 | 7.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 1.0 | 10.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 1.0 | 1.0 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) |
| 0.9 | 12.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.9 | 87.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.9 | 99.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.9 | 17.3 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.9 | 2.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.9 | 46.5 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.9 | 2.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.9 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
| 0.9 | 5.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.9 | 1.8 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.9 | 16.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.9 | 1.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.9 | 2.7 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.9 | 253.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.9 | 10.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.9 | 6.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.9 | 21.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.8 | 1.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.8 | 2.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.8 | 4.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.8 | 1.7 | GO:1990357 | terminal web(GO:1990357) |
| 0.8 | 2.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.8 | 6.5 | GO:0043196 | varicosity(GO:0043196) |
| 0.8 | 8.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.8 | 1.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.8 | 4.0 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.8 | 51.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.8 | 7.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.8 | 1.6 | GO:0034657 | GID complex(GO:0034657) |
| 0.8 | 6.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.8 | 2.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.8 | 11.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.8 | 0.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.8 | 1.6 | GO:0089701 | U2AF(GO:0089701) |
| 0.8 | 0.8 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.8 | 3.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.8 | 52.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.8 | 2.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.8 | 5.4 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.8 | 2.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.8 | 6.1 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.8 | 5.3 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.7 | 3.7 | GO:0000938 | GARP complex(GO:0000938) |
| 0.7 | 2.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.7 | 8.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.7 | 0.7 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.7 | 4.4 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.7 | 1.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.7 | 2.9 | GO:0030904 | retromer complex(GO:0030904) |
| 0.7 | 0.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.7 | 14.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.7 | 4.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.7 | 7.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.7 | 1.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.7 | 6.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.7 | 24.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.7 | 4.9 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.7 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.7 | 6.2 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.7 | 70.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.7 | 6.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.7 | 2.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.7 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.7 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.7 | 1.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.7 | 4.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.7 | 2.7 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.7 | 2.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.7 | 14.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.7 | 18.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.7 | 3.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.6 | 1.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.6 | 377.7 | GO:0016604 | nuclear body(GO:0016604) |
| 0.6 | 3.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.6 | 5.7 | GO:0034709 | methylosome(GO:0034709) |
| 0.6 | 2.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.6 | 4.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.6 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.6 | 73.0 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.6 | 3.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.6 | 2.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.6 | 0.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.6 | 2.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.6 | 1.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.6 | 7.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.6 | 3.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.6 | 1.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.6 | 61.2 | GO:0005903 | brush border(GO:0005903) |
| 0.6 | 2.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.6 | 6.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.5 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.5 | 7.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.5 | 0.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.5 | 232.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.5 | 2.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.5 | 0.5 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.5 | 2.0 | GO:0031417 | NatC complex(GO:0031417) |
| 0.5 | 34.6 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.5 | 3.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.5 | 2.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.5 | 1.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.5 | 13.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.5 | 7.5 | GO:0000786 | nucleosome(GO:0000786) |
| 0.5 | 22.1 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.5 | 3.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.5 | 5.5 | GO:0002102 | podosome(GO:0002102) |
| 0.5 | 33.3 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.5 | 13.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.4 | 1.8 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.4 | 6.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.4 | 28.3 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.4 | 1.3 | GO:0005884 | actin filament(GO:0005884) |
| 0.4 | 3.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.4 | 1.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.4 | 93.8 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.4 | 3.9 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.4 | 1.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.4 | 6.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.4 | 7.5 | GO:0098552 | side of membrane(GO:0098552) |
| 0.4 | 1.5 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.4 | 4.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.4 | 7.0 | GO:0008305 | integrin complex(GO:0008305) |
| 0.4 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.4 | 0.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.4 | 5.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.4 | 0.7 | GO:0031213 | RSF complex(GO:0031213) |
| 0.4 | 6.8 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.4 | 2.5 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.4 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.3 | 5.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.3 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
| 0.3 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 1.0 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
| 0.3 | 3.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.3 | 2.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.3 | 3.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.3 | 13.1 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 1.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.3 | 2.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.3 | 3.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.3 | 1.0 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.3 | 16.3 | GO:0031514 | motile cilium(GO:0031514) |
| 0.3 | 2.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.3 | 2.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 1.2 | GO:0005814 | centriole(GO:0005814) microtubule organizing center part(GO:0044450) |
| 0.3 | 1.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.3 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.3 | 9.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.3 | 7.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.3 | 1.4 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.3 | 15.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.3 | 2.4 | GO:0016235 | aggresome(GO:0016235) |
| 0.3 | 0.8 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.3 | 2.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 0.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.3 | 7.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.3 | 542.5 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.3 | 0.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
| 0.2 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 1.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.2 | 0.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 0.6 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
| 0.2 | 4.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.2 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.2 | 8.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.2 | 5.6 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.2 | 1.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.2 | 1.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 0.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.2 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.2 | 7.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
| 0.2 | 5.0 | GO:0016459 | myosin complex(GO:0016459) |
| 0.2 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 19.4 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.2 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 1.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 6.5 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.1 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 4.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 2.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 0.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.1 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.1 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 4.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 3.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.1 | 3.2 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.1 | 10.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 1.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 2.4 | GO:0030175 | filopodium(GO:0030175) |
| 0.1 | 7.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.1 | 3.7 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.1 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 5.9 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
| 0.0 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 4.3 | GO:0070160 | occluding junction(GO:0070160) |
| 0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.0 | 9.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.0 | 1.0 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 91.2 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 1.9 | GO:0030016 | myofibril(GO:0030016) |
| 0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 17.0 | 85.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 12.5 | 37.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 12.5 | 49.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 11.6 | 11.6 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 9.8 | 39.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 9.6 | 48.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 9.3 | 28.0 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 8.3 | 41.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 7.4 | 22.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 7.1 | 42.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 7.0 | 48.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 7.0 | 34.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 7.0 | 27.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 6.9 | 20.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 6.9 | 41.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 6.8 | 20.3 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 6.7 | 20.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 6.6 | 126.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 6.4 | 116.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 6.3 | 25.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 5.9 | 17.8 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 5.8 | 29.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 5.8 | 46.3 | GO:0005497 | androgen binding(GO:0005497) |
| 5.8 | 34.6 | GO:0046979 | TAP2 binding(GO:0046979) |
| 5.7 | 17.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 5.7 | 34.4 | GO:0039552 | RIG-I binding(GO:0039552) |
| 5.7 | 17.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 5.7 | 28.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 5.6 | 22.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 5.4 | 76.3 | GO:0031014 | troponin T binding(GO:0031014) |
| 5.4 | 27.0 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 5.4 | 16.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 5.3 | 26.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 5.2 | 36.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 5.1 | 20.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 5.0 | 20.0 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 5.0 | 19.9 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 5.0 | 19.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 4.9 | 14.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 4.9 | 4.9 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 4.9 | 43.7 | GO:0043426 | MRF binding(GO:0043426) |
| 4.8 | 19.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 4.7 | 19.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 4.7 | 46.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 4.5 | 18.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 4.5 | 40.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 4.4 | 17.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 4.4 | 8.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 4.3 | 21.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 4.2 | 16.9 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 4.2 | 12.5 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 4.1 | 20.4 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 4.0 | 16.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 4.0 | 12.0 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 3.9 | 11.7 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 3.9 | 31.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 3.9 | 19.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 3.9 | 3.9 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 3.8 | 42.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 3.8 | 193.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 3.7 | 11.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 3.6 | 10.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 3.6 | 3.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 3.6 | 46.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 3.6 | 7.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 3.5 | 49.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 3.5 | 13.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 3.5 | 13.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 3.5 | 20.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 3.3 | 33.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 3.3 | 33.4 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 3.3 | 10.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 3.3 | 9.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 3.3 | 52.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 3.3 | 19.6 | GO:1990254 | keratin filament binding(GO:1990254) |
| 3.2 | 9.7 | GO:0034584 | piRNA binding(GO:0034584) |
| 3.2 | 9.7 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 3.2 | 54.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 3.2 | 3.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 3.1 | 31.3 | GO:0015925 | galactosidase activity(GO:0015925) |
| 3.1 | 53.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 3.1 | 9.4 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 3.1 | 9.3 | GO:0043398 | HLH domain binding(GO:0043398) |
| 3.1 | 9.3 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 3.0 | 9.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 3.0 | 36.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 3.0 | 21.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 3.0 | 6.0 | GO:0030911 | TPR domain binding(GO:0030911) |
| 3.0 | 9.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 3.0 | 3.0 | GO:0032427 | GBD domain binding(GO:0032427) |
| 2.9 | 8.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 2.9 | 8.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 2.9 | 20.1 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 2.8 | 11.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 2.8 | 8.4 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
| 2.8 | 16.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 2.8 | 13.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 2.8 | 38.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 2.8 | 33.0 | GO:0045159 | myosin II binding(GO:0045159) |
| 2.7 | 8.0 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 2.7 | 8.0 | GO:0048030 | disaccharide binding(GO:0048030) |
| 2.7 | 10.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 2.6 | 18.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 2.6 | 79.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 2.6 | 5.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 2.6 | 7.9 | GO:0004103 | choline kinase activity(GO:0004103) |
| 2.6 | 7.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 2.6 | 2.6 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 2.6 | 28.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 2.5 | 66.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 2.5 | 45.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 2.5 | 7.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 2.5 | 32.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 2.5 | 7.4 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 2.5 | 9.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 2.5 | 22.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 2.4 | 7.3 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 2.4 | 7.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 2.4 | 4.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 2.4 | 7.2 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 2.4 | 4.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 2.4 | 103.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 2.4 | 100.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 2.4 | 9.5 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 2.4 | 11.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 2.3 | 23.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 2.3 | 11.6 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 2.3 | 2.3 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 2.3 | 27.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 2.3 | 9.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 2.3 | 34.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 2.2 | 2.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 2.2 | 6.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 2.2 | 8.9 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 2.2 | 28.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 2.2 | 13.3 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 2.2 | 10.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 2.2 | 4.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 2.1 | 23.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 2.1 | 10.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 2.1 | 37.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 2.1 | 6.3 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 2.1 | 4.2 | GO:0097617 | annealing activity(GO:0097617) |
| 2.1 | 14.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 2.1 | 6.2 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 2.1 | 24.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 2.1 | 8.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 2.0 | 38.7 | GO:0015923 | mannosidase activity(GO:0015923) |
| 2.0 | 26.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 2.0 | 12.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 2.0 | 40.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 2.0 | 6.1 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 2.0 | 37.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 2.0 | 6.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 2.0 | 7.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 2.0 | 11.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 2.0 | 5.9 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 2.0 | 15.8 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 2.0 | 115.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 1.9 | 11.7 | GO:0050693 | LBD domain binding(GO:0050693) |
| 1.9 | 5.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 1.9 | 26.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 1.9 | 20.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 1.9 | 15.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 1.9 | 11.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.9 | 1.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.9 | 1.9 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 1.9 | 7.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 1.9 | 28.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.9 | 5.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 1.9 | 5.6 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 1.9 | 37.0 | GO:0043495 | protein anchor(GO:0043495) |
| 1.9 | 57.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 1.8 | 5.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 1.8 | 16.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 1.8 | 5.5 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 1.8 | 7.3 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 1.8 | 7.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 1.8 | 14.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 1.8 | 71.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 1.8 | 5.4 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 1.8 | 5.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 1.8 | 5.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 1.8 | 55.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 1.8 | 25.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 1.8 | 32.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 1.8 | 7.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 1.8 | 23.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 1.8 | 7.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 1.8 | 12.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 1.8 | 7.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 1.8 | 5.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 1.8 | 10.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 1.7 | 7.0 | GO:0035939 | microsatellite binding(GO:0035939) |
| 1.7 | 13.7 | GO:0019863 | IgE binding(GO:0019863) |
| 1.7 | 47.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 1.7 | 1.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 1.7 | 20.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 1.7 | 6.8 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 1.7 | 57.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 1.7 | 5.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 1.7 | 6.8 | GO:0051373 | FATZ binding(GO:0051373) |
| 1.7 | 32.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 1.7 | 5.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 1.7 | 10.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 1.7 | 10.1 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 1.7 | 5.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 1.7 | 5.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 1.7 | 13.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 1.7 | 34.9 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 1.7 | 21.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 1.7 | 13.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 1.7 | 14.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 1.6 | 6.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 1.6 | 3.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.6 | 4.9 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 1.6 | 21.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 1.6 | 70.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 1.6 | 8.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 1.6 | 11.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 1.6 | 48.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 1.6 | 6.4 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 1.6 | 6.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 1.6 | 4.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.6 | 12.6 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
| 1.6 | 89.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 1.6 | 42.3 | GO:0030506 | ankyrin binding(GO:0030506) |
| 1.6 | 4.7 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 1.6 | 3.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 1.6 | 4.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 1.5 | 6.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 1.5 | 12.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 1.5 | 4.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 1.5 | 51.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 1.5 | 7.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 1.5 | 6.0 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 1.5 | 19.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 1.5 | 12.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 1.5 | 11.9 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 1.5 | 6.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 1.5 | 4.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 1.5 | 7.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 1.5 | 8.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 1.5 | 7.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 1.5 | 4.4 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 1.5 | 210.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 1.5 | 4.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 1.5 | 2.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 1.5 | 39.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 1.5 | 11.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 1.4 | 18.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 1.4 | 40.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 1.4 | 4.3 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 1.4 | 5.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 1.4 | 5.6 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 1.4 | 29.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 1.4 | 51.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 1.4 | 2.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 1.4 | 20.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 1.4 | 8.3 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 1.4 | 5.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.4 | 4.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 1.4 | 12.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 1.4 | 9.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 1.4 | 9.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.4 | 5.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 1.4 | 10.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 1.3 | 8.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 1.3 | 28.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 1.3 | 34.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 1.3 | 26.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 1.3 | 22.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 1.3 | 11.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 1.3 | 7.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.3 | 27.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 1.3 | 14.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
| 1.3 | 23.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 1.3 | 6.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 1.3 | 1.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 1.3 | 15.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 1.3 | 14.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 1.3 | 20.5 | GO:0070513 | death domain binding(GO:0070513) |
| 1.3 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 1.3 | 14.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 1.3 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 1.3 | 2.5 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
| 1.3 | 16.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 1.3 | 46.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 1.3 | 6.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 1.3 | 6.3 | GO:0031013 | troponin I binding(GO:0031013) |
| 1.2 | 39.8 | GO:0005123 | death receptor binding(GO:0005123) |
| 1.2 | 12.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 1.2 | 1.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 1.2 | 7.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 1.2 | 8.6 | GO:0089720 | caspase binding(GO:0089720) |
| 1.2 | 3.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 1.2 | 7.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 1.2 | 4.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 1.2 | 3.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 1.2 | 6.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 1.2 | 2.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 1.2 | 3.6 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 1.2 | 4.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 1.2 | 3.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.2 | 37.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 1.2 | 18.8 | GO:0019213 | deacetylase activity(GO:0019213) |
| 1.2 | 3.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 1.2 | 3.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 1.2 | 3.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 1.2 | 10.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 1.2 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 1.1 | 5.7 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 1.1 | 28.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 1.1 | 4.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 1.1 | 15.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 1.1 | 1.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 1.1 | 6.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 1.1 | 7.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 1.1 | 11.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 1.1 | 82.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 1.1 | 17.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 1.1 | 3.3 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 1.1 | 18.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 1.1 | 8.7 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 1.1 | 6.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 1.1 | 3.2 | GO:0035673 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) |
| 1.1 | 6.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 1.1 | 4.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 1.1 | 24.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 1.1 | 4.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 1.0 | 9.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 1.0 | 20.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 1.0 | 2.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 1.0 | 1.0 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 1.0 | 11.3 | GO:0004875 | complement receptor activity(GO:0004875) |
| 1.0 | 4.1 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 1.0 | 31.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 1.0 | 9.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 1.0 | 11.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 1.0 | 4.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 1.0 | 10.1 | GO:0030332 | cyclin binding(GO:0030332) |
| 1.0 | 7.1 | GO:0050733 | RS domain binding(GO:0050733) |
| 1.0 | 7.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 1.0 | 6.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 1.0 | 3.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.0 | 5.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 1.0 | 2.9 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 1.0 | 10.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 1.0 | 13.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 1.0 | 2.9 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.0 | 2.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.0 | 26.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 1.0 | 1.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.0 | 6.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 1.0 | 2.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 1.0 | 55.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.9 | 2.8 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.9 | 7.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.9 | 1.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.9 | 16.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.9 | 15.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.9 | 19.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.9 | 2.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.9 | 29.3 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.9 | 2.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.9 | 2.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.9 | 2.7 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.9 | 20.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.9 | 287.4 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
| 0.9 | 2.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.9 | 2.7 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.9 | 2.7 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.9 | 1.8 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.9 | 5.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.9 | 1.8 | GO:0051379 | epinephrine binding(GO:0051379) |
| 0.9 | 2.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.9 | 6.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.9 | 0.9 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.9 | 8.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.9 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.9 | 1.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.9 | 9.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.9 | 6.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.9 | 12.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.9 | 6.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.8 | 5.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.8 | 1.7 | GO:0086075 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.8 | 5.1 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.8 | 2.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.8 | 38.4 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.8 | 28.3 | GO:0002039 | p53 binding(GO:0002039) |
| 0.8 | 1.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.8 | 4.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.8 | 1.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.8 | 5.8 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.8 | 3.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 0.8 | 2.4 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.8 | 3.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.8 | 1.6 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.8 | 5.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.8 | 11.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.8 | 4.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.8 | 1.6 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.8 | 3.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.8 | 11.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.8 | 2.4 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.8 | 4.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.8 | 7.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.8 | 4.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.8 | 1.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.8 | 1.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.8 | 11.8 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.8 | 23.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.8 | 7.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.8 | 18.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.8 | 5.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.8 | 2.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.8 | 3.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.8 | 2.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.8 | 2.3 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.8 | 41.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.8 | 236.8 | GO:0000975 | regulatory region DNA binding(GO:0000975) |
| 0.8 | 26.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.8 | 3.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.8 | 3.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.8 | 12.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.8 | 3.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.7 | 2.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.7 | 1.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.7 | 2.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.7 | 38.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.7 | 4.4 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.7 | 17.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.7 | 2.9 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.7 | 5.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.7 | 35.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.7 | 2.9 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.7 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.7 | 5.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.7 | 5.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.7 | 4.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.7 | 39.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.7 | 1.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.7 | 5.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.7 | 2.1 | GO:0048185 | activin binding(GO:0048185) |
| 0.7 | 5.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.7 | 14.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.7 | 4.9 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.7 | 6.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.7 | 3.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.7 | 4.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.7 | 2.1 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.7 | 2.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.7 | 14.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.7 | 2.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.7 | 15.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.7 | 36.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.7 | 9.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.7 | 5.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.7 | 1.4 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.7 | 2.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.7 | 12.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.7 | 9.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.7 | 7.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.6 | 9.7 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.6 | 0.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.6 | 4.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.6 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.6 | 3.9 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.6 | 2.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.6 | 15.9 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.6 | 2.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.6 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.6 | 14.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.6 | 9.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.6 | 2.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.6 | 3.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.6 | 12.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.6 | 4.4 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.6 | 1.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.6 | 152.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.6 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.6 | 0.6 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.6 | 3.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.6 | 9.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.6 | 2.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.6 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.6 | 60.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.6 | 2.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.6 | 37.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.6 | 27.7 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.6 | 3.0 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.6 | 1.8 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.6 | 9.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.6 | 14.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.6 | 3.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.6 | 26.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.6 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
| 0.6 | 7.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.6 | 9.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.6 | 2.8 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.6 | 2.3 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.6 | 11.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.6 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.6 | 1.7 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.6 | 1.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.6 | 15.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.6 | 2.8 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.5 | 106.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.5 | 10.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.5 | 3.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.5 | 1.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.5 | 4.4 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.5 | 4.9 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.5 | 1.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.5 | 4.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.5 | 8.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.5 | 17.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.5 | 1.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.5 | 1.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.5 | 2.1 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.5 | 2.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.5 | 1.6 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.5 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.5 | 6.2 | GO:0019864 | IgG binding(GO:0019864) |
| 0.5 | 7.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.5 | 1.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.5 | 1.5 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
| 0.5 | 57.2 | GO:0004175 | endopeptidase activity(GO:0004175) |
| 0.5 | 3.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.5 | 3.0 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.5 | 1.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.5 | 1.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.5 | 1.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.5 | 0.5 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.5 | 12.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.5 | 14.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.5 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.5 | 1.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.5 | 1.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.5 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.5 | 0.5 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.5 | 3.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.5 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.5 | 5.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.5 | 1.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.5 | 1.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.5 | 120.6 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
| 0.5 | 81.5 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.5 | 1.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.5 | 6.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.5 | 1.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.5 | 9.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.5 | 1.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.4 | 2.7 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.4 | 4.0 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.4 | 0.9 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.4 | 36.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.4 | 21.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.4 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.4 | 3.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.4 | 1.7 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.4 | 1.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.4 | 7.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
| 0.4 | 4.6 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.4 | 0.8 | GO:0000829 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.4 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 1.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.4 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.4 | 36.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.4 | 1.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.4 | 13.9 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.4 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.4 | 3.9 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.4 | 1.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.4 | 10.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.4 | 1.9 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 2.7 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.4 | 7.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.4 | 4.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.4 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.4 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.4 | 2.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.4 | 3.7 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.4 | 0.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.4 | 0.7 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.4 | 0.4 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
| 0.4 | 3.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.4 | 0.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.4 | 1.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.4 | 1.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.4 | 1.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.4 | 1.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.3 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.3 | 2.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.3 | 10.8 | GO:0019955 | cytokine binding(GO:0019955) |
| 0.3 | 1.7 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.3 | 1.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.3 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.3 | 2.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.3 | 2.0 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.3 | 42.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.3 | 2.0 | GO:0017022 | myosin binding(GO:0017022) |
| 0.3 | 3.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.3 | 1.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.3 | 2.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.3 | 1.0 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.3 | 1.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.3 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.3 | 2.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.3 | 0.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.3 | 3.0 | GO:0005537 | mannose binding(GO:0005537) |
| 0.3 | 2.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.3 | 9.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.3 | 1.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 2.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.3 | 13.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.3 | 1.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.3 | 0.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.3 | 1.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.3 | 31.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
| 0.3 | 2.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.3 | 2.0 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.3 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.3 | 12.2 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) endopeptidase regulator activity(GO:0061135) |
| 0.3 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.3 | 1.4 | GO:0016208 | AMP binding(GO:0016208) |
| 0.3 | 25.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.3 | 2.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.3 | 0.8 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.3 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.3 | 0.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.3 | 3.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.3 | 1.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.2 | 6.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 0.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.2 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.2 | 2.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.2 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.2 | 8.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 2.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.2 | 0.7 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.2 | 1.6 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.2 | 1.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 2.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 43.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 0.7 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.2 | 2.2 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.2 | 1.6 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.2 | 0.9 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.2 | 0.4 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.2 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.2 | 2.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.2 | 0.8 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.2 | 30.9 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.2 | 0.6 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.2 | 2.5 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.2 | 0.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.2 | 0.6 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.2 | 14.1 | GO:0003823 | antigen binding(GO:0003823) |
| 0.2 | 1.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.2 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 0.8 | GO:0045118 | azole transporter activity(GO:0045118) |
| 0.2 | 4.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.2 | 0.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.2 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.2 | 1.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 1.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.2 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.2 | 0.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 6.1 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
| 0.2 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.2 | 1.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 6.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.2 | 1.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 0.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.2 | 0.9 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.2 | 0.5 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.2 | 2.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 0.9 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.2 | 1.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 5.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.2 | 4.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.2 | 0.8 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.2 | 0.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.2 | 1.8 | GO:0008237 | metallopeptidase activity(GO:0008237) |
| 0.2 | 3.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.2 | 0.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 1.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.1 | 0.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.1 | 0.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 1.4 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.1 | 0.4 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.1 | 2.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 0.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 1.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 1.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 1.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.1 | 0.6 | GO:1901338 | dopamine binding(GO:0035240) catecholamine binding(GO:1901338) |
| 0.1 | 0.1 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.1 | 1.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.9 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.1 | 0.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 2.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 4.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 2.2 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
| 0.1 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.1 | 0.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) |
| 0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.1 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 10.5 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
| 0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.1 | 4.3 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 2.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.1 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 1.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.1 | 1.6 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.1 | 2.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.1 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.1 | 0.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.8 | GO:0048038 | quinone binding(GO:0048038) |
| 0.1 | 1.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.1 | 5.6 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.1 | 0.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.1 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.0 | 0.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.0 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
| 0.0 | 0.2 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.0 | 5.5 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 0.0 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.0 | 1.4 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.0 | 0.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
| 0.0 | 0.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.0 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.0 | 0.7 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
| 0.0 | 0.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.0 | 0.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 0.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 37.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 3.6 | 10.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 3.4 | 143.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 3.3 | 136.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 3.1 | 105.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 2.7 | 2.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 2.6 | 194.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 2.6 | 20.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 2.5 | 58.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 2.4 | 68.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 2.4 | 69.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 2.3 | 37.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 2.3 | 18.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 2.3 | 91.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 2.2 | 20.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 2.1 | 58.0 | PID EPO PATHWAY | EPO signaling pathway |
| 2.1 | 74.5 | PID IFNG PATHWAY | IFN-gamma pathway |
| 2.1 | 4.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 2.0 | 33.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 1.9 | 71.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 1.9 | 11.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 1.8 | 33.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 1.8 | 3.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 1.8 | 66.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 1.8 | 96.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 1.8 | 121.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 1.7 | 56.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 1.7 | 3.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 1.6 | 38.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 1.5 | 34.3 | PID RAS PATHWAY | Regulation of Ras family activation |
| 1.5 | 100.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 1.4 | 14.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 1.4 | 25.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 1.4 | 17.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 1.4 | 157.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 1.4 | 60.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 1.4 | 51.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 1.4 | 74.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 1.3 | 7.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 1.3 | 15.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 1.3 | 36.3 | PID ALK1 PATHWAY | ALK1 signaling events |
| 1.3 | 76.1 | PID P53 REGULATION PATHWAY | p53 pathway |
| 1.3 | 16.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 1.2 | 65.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 1.2 | 35.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 1.2 | 28.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 1.1 | 6.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 1.1 | 1.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 1.1 | 3.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 1.1 | 17.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 1.1 | 19.0 | PID FOXO PATHWAY | FoxO family signaling |
| 1.1 | 48.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 1.1 | 38.9 | PID RHOA PATHWAY | RhoA signaling pathway |
| 1.1 | 16.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 1.1 | 3.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 1.0 | 65.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 1.0 | 10.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 1.0 | 35.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 1.0 | 19.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 1.0 | 10.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.9 | 38.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.9 | 17.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.9 | 32.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.9 | 6.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.9 | 23.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.9 | 32.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.9 | 12.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.9 | 43.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.8 | 8.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.8 | 6.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.8 | 25.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.8 | 1.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.8 | 9.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.7 | 121.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.7 | 46.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.7 | 1.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.7 | 12.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.7 | 158.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.7 | 22.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.6 | 11.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.6 | 21.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.6 | 4.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.6 | 16.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.6 | 23.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.6 | 23.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.5 | 25.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.5 | 77.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.5 | 12.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.5 | 10.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.5 | 3.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.5 | 14.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.5 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.4 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.4 | 5.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.4 | 3.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.4 | 2.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.4 | 12.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.4 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.4 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.3 | 25.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.3 | 5.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.3 | 17.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.3 | 19.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.3 | 9.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 10.8 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.2 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 6.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.2 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 40.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 6.3 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 3.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 1.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 3.6 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 2.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 2.5 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 4.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 3.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 0.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 22.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.0 | 1.8 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 53.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 5.2 | 10.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 4.3 | 68.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 4.0 | 95.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 4.0 | 19.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 3.9 | 47.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 3.6 | 3.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 3.5 | 34.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 3.4 | 86.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 3.3 | 143.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 3.1 | 58.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 3.1 | 6.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 3.0 | 106.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 2.8 | 51.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 2.7 | 130.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 2.6 | 67.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 2.5 | 61.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 2.2 | 8.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 2.1 | 36.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 2.1 | 56.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 2.1 | 39.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 2.0 | 28.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 2.0 | 52.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 1.9 | 11.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 1.9 | 1.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.8 | 36.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 1.8 | 3.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 1.8 | 1.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 1.8 | 10.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 1.7 | 27.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 1.7 | 20.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 1.7 | 118.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 1.7 | 17.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 1.7 | 52.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 1.7 | 43.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 1.6 | 50.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 1.6 | 14.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 1.6 | 17.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 1.6 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 1.5 | 68.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 1.5 | 40.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 1.5 | 7.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 1.4 | 54.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 1.3 | 6.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 1.3 | 22.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 1.3 | 28.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 1.3 | 11.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 1.3 | 6.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 1.3 | 43.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 1.3 | 12.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 1.3 | 32.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 1.3 | 84.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 1.3 | 23.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 1.2 | 97.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 1.2 | 21.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 1.2 | 1.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 1.2 | 187.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 1.2 | 187.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 1.1 | 6.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 1.1 | 17.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 1.1 | 16.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 1.1 | 16.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 1.1 | 20.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 1.1 | 10.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 1.0 | 60.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 1.0 | 7.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 1.0 | 20.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.0 | 11.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 1.0 | 7.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 1.0 | 9.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 1.0 | 19.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 1.0 | 31.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 1.0 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 1.0 | 15.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 1.0 | 6.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.9 | 17.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.9 | 23.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.9 | 10.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.9 | 20.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.9 | 21.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.9 | 11.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.9 | 15.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.9 | 18.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.9 | 67.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.9 | 17.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.9 | 50.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.9 | 33.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.9 | 12.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.9 | 131.2 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.8 | 25.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.8 | 57.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.8 | 18.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.8 | 22.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.8 | 30.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.8 | 18.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.8 | 8.6 | REACTOME OPSINS | Genes involved in Opsins |
| 0.8 | 105.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.8 | 28.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.8 | 38.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.8 | 10.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.8 | 57.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.7 | 4.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.7 | 10.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.7 | 32.9 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.7 | 14.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.7 | 2.0 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.7 | 53.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.7 | 19.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.7 | 19.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.7 | 18.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.7 | 2.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.6 | 5.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.6 | 30.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.6 | 10.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.6 | 11.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.6 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.6 | 1.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.6 | 4.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.6 | 11.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.6 | 8.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.6 | 6.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.5 | 11.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.5 | 10.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.5 | 13.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.5 | 1.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.5 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.5 | 2.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.5 | 14.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.5 | 12.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.5 | 8.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 3.0 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.5 | 4.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.5 | 8.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.5 | 11.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.5 | 3.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.5 | 7.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.5 | 7.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.5 | 10.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.4 | 3.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.4 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.4 | 6.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.4 | 20.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.4 | 5.5 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.4 | 14.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.4 | 6.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.4 | 9.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.4 | 3.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.4 | 5.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.4 | 3.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.4 | 8.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.4 | 2.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.4 | 2.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.4 | 6.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.4 | 8.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.3 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.3 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.3 | 10.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.3 | 10.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.3 | 5.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.3 | 6.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.3 | 12.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.3 | 4.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.3 | 2.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.3 | 2.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.3 | 0.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.3 | 2.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.3 | 4.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.3 | 5.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 4.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.3 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.3 | 8.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 6.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.2 | 15.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 0.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.2 | 12.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 4.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 7.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.2 | 22.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.2 | 3.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 2.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.2 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.2 | 18.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.2 | 1.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.2 | 1.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.1 | 1.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.1 | 2.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 1.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.1 | 2.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 1.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 2.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 5.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 4.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 1.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.0 | 2.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |